{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import datetime\n",
    "import time\n",
    "import os"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "This notebook outputs the input for MedNLI and the output from it.\n",
    "\n",
    "The steps in this workflow are:\n",
    "\n",
    "-Extract sentences of interest from an existing dataframe.\n",
    "-Write tab-separated pairs of sentences to a text file.\n",
    "-Run the \"predict.py\" script in the MedNLI folder (https://github.com/jgc128/mednli_baseline) on the sentence file\n",
    "and pretrained models, generating a score/prediction file.\n",
    "-Merge the original sentences with the score/prediction table.\n",
    "\n",
    "Todo:\n",
    "\n",
    "    -The pretrained models all predate covid-19 by a year.  Try replacing all covid-19 synonyms in the input sentence with \"influenza\" and see how this affects results.\n",
    "    -Write a bash script for the automatic execution of predict.py on all input sentence files in a directory.\n",
    "    -Research if it's possible to retrain or modify the existing models to direct attention exclusively to covid-19 and drug terms.\n",
    "    \n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "timestr = time.strftime(\"%Y%m%d\")\n",
    "\n",
    "\"\"\"\n",
    "Input\n",
    "\"\"\"\n",
    "\n",
    "input_dir = '../../../../resources/mednli/input/'\n",
    "\n",
    "sent_df_path = '%s/sents_with_cov19_and_drugs_200505.csv' % input_dir\n",
    "claims_df_path = '%s/claims_flag_sentence_cord_uid.csv' % input_dir\n",
    "\n",
    "#Sentence files are written to a date-specific folder\n",
    "date_input_dir = '%s%s' % (input_dir, timestr)\n",
    "\n",
    "if not os.path.isdir(date_input_dir):\n",
    "    os.mkdir('%s%s' % (input_dir,timestr))\n",
    "\n",
    "chloro_sents_outpath = '%s/chloro_sents_%s.txt' % (date_input_dir, timestr)\n",
    "chloro_claims_outpath = '%s/chloro_claim_sents_%s.txt' % (date_input_dir, timestr)\n",
    "    \n",
    "\"\"\"\n",
    "MedNLI script directory\n",
    "\"\"\"\n",
    "\n",
    "mednli_dir = '../../../../notebooks/mednli_baseline/'\n",
    "\n",
    "\"\"\"\n",
    "Output\n",
    "\"\"\"\n",
    "\n",
    "output_dir = '../../../../resources/mednli/output/'\n",
    "\n",
    "\n",
    "#Sentence/score tables are written to a date-specific folder\n",
    "date_output_dir = '%s%s' % (output_dir, timestr)\n",
    "\n",
    "if not os.path.isdir(date_output_dir):\n",
    "    os.mkdir('%s%s' % (output_dir,timestr))\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [],
   "source": [
    "sents_df = pd.read_csv(sent_df_path)\n",
    "chloro_sent_df = sents_df.loc[sents_df.entities.str.contains('chloroquine')]\n",
    "chloro_sents = chloro_sent_df.text.tolist()\n",
    "\n",
    "claims_df = pd.read_csv(claims_df_path)\n",
    "claims_df = df.loc[df.claims.str.len() > 2]\n",
    "claims_df = claims_df.drop_duplicates(subset=['claims'])\n",
    "chloro_claim_sents = claims_df.loc[claims_df.drug_terms_used.str.contains('chloroquine')].claims.tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[' this study confirms that fever, cough, and breathing difficulties are the major symptoms of covid-19 infection among pregnant women, which are similar to general infected patients.',\n",
       " 'this would be the first successful use of cq in humans for treating acute viral disease.',\n",
       " 'it is also recommended to further research on the role of cq for covid-19 prevention.',\n",
       " 'it has also been urged in an article that the above cq regimens be investigated in parallel with the mass deployment of this drug, without unnecessary regulatory delays, in an attempt to contain the global pandemic as the benefits of cq far outweigh the risks or costs.',\n",
       " 'more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.',\n",
       " '48 however, absolute risk in our study should be interpreted cautiously since patients with ra are likely different from those with covid-19.',\n",
       " 'as the world awaits the results of clinical trials for the anti-viral efficacy of hcq in the treatment of sars-cov2 infection, this large scale, international real-world data network study enables us to consider the safety of the most popular drugs under consideration.',\n",
       " 'hcq appears to be largely safe in both direct and comparative analysis for short term use, but when used in combination with azm this therapy carries double the risk of cardiovascular death in patients with ra.',\n",
       " 'whereas we used the collective experience of a million patients to build our confidence in the evidence around the safety profile, the current evidence around efficacy of hcq+azi in the treatment of covid-19 is quite limited and controversial.',\n",
       " 'the findings of the survey may help shape future evidence-based opinions on managing patients with is during covid-19 pandemic.',\n",
       " 'these results may provide insight into the immunomodulation mechanisms of hcq treatment in the setting of covid-19 and suggest hcq all rights reserved.',\n",
       " ' comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.',\n",
       " 'the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.',\n",
       " 'the measures of restrained advocacy for potentially beneficial effects of hcq and advice against self-medication can help prevent adverse events related to this drug.',\n",
       " 'these results can contribute to guide the design of new functional and high specific mabs providing a cost-and-time-effective computational framework towards the development of better diagnostic strategies and an effective treatment and/or vaccine for covid-19.',\n",
       " 'the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.',\n",
       " 'in fact, one can argue that the alleged tocilizumab efficacy both for treating covid-19 and iraes might suggest a potentially increased danger from sars-cov-2 infection for ici-treated patients, maybe hypothesizing a synergy in the promotion of the viral morbidity.',\n",
       " 'thus, hoping for positive results from tocilizumab randomized clinical trial on covid-19 patients, we could only argue about the evident diversity of this viral infection from previous sars outbreaks and even more from influenza epidemics, probably both in terms of clinical features and of pathogenetic implications.',\n",
       " '17 this indicate that eosinophils could assist in the diagnosis and severity assessment of covid-19.',\n",
       " 'it is hoped that our study may provide the basis for the epidemiology related measures of patients in covid-19 import area as well as for clinicians to make medical decisions.',\n",
       " 'therefore, the treatment experience in our study should be carefully thought when treating patients in different places and circumstances, and further researches are needed to verify the the safety and efficacy.',\n",
       " 'our findings could be further validated in an appropriate animal model, and hopefully developed through subsequent clinical trials in order to provide additional therapeutic options for patients with covid-19.',\n",
       " ' for ethical reasons and because our first results are so significant and evident we decide to share our findings with the medical community, given the urgent need for an effective drug against sars-cov-2 in the current pandemic context.',\n",
       " 'we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.',\n",
       " 'we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.',\n",
       " 'further works are also warranted to determine if these compounds could be useful as chemoprophylaxis to prevent the transmission of the virus, especially for healthcare workers.',\n",
       " 'our study has some limitations including a small sample size, limited long-term outcome follow-up, and dropout of six patients from the study, however in the current context, we believe that our results should be shared with the scientific community.',\n",
       " 'despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.',\n",
       " 'further research should be directed toward the study of sars-cov-2 in suitable animal models for analyzing replication, transmission, and pathogenesis.',\n",
       " 'to best of our knowledge, this is the first study to identify certain peptides in envelope (e',\n",
       " 'we should therefore act cautiously before initiating prospective interventional studies on the use of hcq',\n",
       " 'results of the clinical trials currently underway in the u.s. and china will provide crucial information about whether remdesivir represents a viable treatment option for covid-19 [20,49].',\n",
       " 'if the trial findings are ultimately positive, it will be imperative to ensure that the drug is produced on a commercial scale capable of meeting the demand generated by both the current pandemic and future outbreaks.',\n",
       " 'such a change in production may also allow for the added benefit of the drug becoming more available for agricultural and veterinary use for relevant indications.',\n",
       " 'these data suggested that isolation for at least 21 days after the onset of symptom or first positive pcr test is warranted in both patients without or with improving symptoms.',\n",
       " 'in patients with covid-19, isolation for a minimum of 21 days after onset of illness may be warranted, while the use of antiviral drugs does not enhance viral rna clearance.',\n",
       " \"and if it does, we hope that this simple qtc surveillance strategy, enabled by innovation and the fda's emergency approval, will help prevent altogether or at least substantially reduce the number of druginduced ventricular arrhythmias and sudden cardiac deaths, particularly if there is widespread adoption and utilization of these medications for covid-19.\",\n",
       " \"with the possibility that a considerable q6', 'cite_spans': [], 'ref_spans': [], 'section': 'abstract'}]\",\n",
       " 'finally, although baricitinib has the potential to affect sars-cov2 penetration into pulmonary epithelial cells, major concerns remain about the inhibition of ifns activity which could be detrimental in the course of viral infection.',\n",
       " 'the authors appraise the study generating this interest and highlight the potential consequences of rapid dissemination of overinterpreted data, particularly for people with conditions for which hydroxychloroquine has demonstrated benefits in preventing organ damage and life-threatening disease flares.',\n",
       " 'these results suggest that this new hcov has evolved with improved binding affinity between hr1 and hr2 domains, which may accelerate the viral membrane fusion process and enhance viral infectivity or transmissibility.',\n",
       " 'ek1c4 showed prolonged and significant prophylactic effect against hcov-oc43 infection in mouse model, suggesting that ek1c4 may also be used as an inhibitor against sars-cov-2 infection in vivo.',\n",
       " 'therefore, ek1c4 shows exceptional promise to be developed as the first pan-cov fusion inhibitor-based antiviral therapeutic or prophylactic for treatment or prevention of infection by the currently circulating sars-cov-2 and mers-cov and the future reemerging sars-cov and emerging sarsr-covs.',\n",
       " 'the trial of gautret and colleagues, with consideration of the effect sizes, and p-values from multiple models, does not provide sufficient evidence to support wide-scale rollout of hcq monotherapy for the treatment of covid-19; larger randomized studies should be considered.',\n",
       " 'these data also suggest further randomized-controlled studies of hcq-az combination therapy should be undertaken.',\n",
       " 'our docking results show that remdesivir-tp binds to sars-cov-2 rdrp, with a score of -112.8, and the docking results are consistent with its original anti-viral mechanism, so we think remdesivir may be good in treating sars-cov-2 pneumonia.',\n",
       " 'these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.',\n",
       " 'conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.',\n",
       " 'we also identify that clinically meaningful drug resistance is less likely to emerge with a highly potent agent that is dosed after peak viral load.',\n",
       " 'our results support an early test and treat approach for covid-19, but also demonstrate the need to identify early viral shedding kinetic features that are the most predictive surrogates of clinical severity and transmission risk.',\n",
       " ' new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?',\n",
       " ' no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection',\n",
       " 'in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.',\n",
       " 'given the urgent therapeutic need to manage this disease with effective and safe drugs, and the negligible cost of both hydroxychloroquine and azithromycin, we believe that there is an urgent need to evaluate this strategy further, both to treat and cure patients at an early stage before irreversible severe respiratory complications take hold, and to decrease duration of carriage and avoid the spread of the disease.',\n",
       " 'in this study, we evidence that the anti-sars-cov2 activity of a clinically achievable hydroxychloroquine concentration is maximized only when administered before and after the infection of vero e6 cells.',\n",
       " 'this strongly suggests that only a combined prophylactic and therapeutic use of hydroxychloroquine may be effective in limiting viral replication in patients.',\n",
       " '1101 /2020 can provide real-time guidance for preventing and controlling the epidemic, assessing development trends and the effects of intervention measures [8] .covid-19\\'s \"war epidemic\" and \"epidemic prevention\" strategies are closely related to the important measure of improving the transparency of clinical trials, including sharing of the subject\\'s original data and standardizing trial design, registration, and implementation [9].',\n",
       " 'these results imply that different interventions have an impact on the design of clinical trials.',\n",
       " 'however, the innovation of this article is to summarize and analyze the registration of chictr\\'s covid-19 clinical research in a timely manner, reflecting the research status and development trend of clinical trials in this field, which is \"time-effective\".',\n",
       " 'however, clinical use should either adhere to the monitored emergency use of unregistered interventions (monitored emergency use of unregistered interventions',\n",
       " 'our studies here show that cf respiratory epithelial cell normalization is based on a neutralization of the pre-existing pathologically hyperacidified compartments due to the underlying cf disease, resulting in normalization of glycosylation in cf respiratory epithelial cells.',\n",
       " 'we postulate here that the acidotropic and neutralization effects of azt, cpx and cq in normal cells would result in vectorially similar ph shifts away from optimal for the function of enzymes within the secretory pathway that would also alter glycosylation.',\n",
       " 'our studies here show that azt can reduce furin activity that is abundantly present in respiratory epithelial cells.',\n",
       " 'we propose that the drugs studied here, cq, azt and cpx, may modulate these aspects of host-pathogen interactions and virus infectious cycle, with immediate compassionate use in the clinic or in controlled clinical trials.',\n",
       " 'we believe this may in part help understand the potentially beneficial effects of cq/hcq and azt in covid-19, and that the present considerations of hcq and azt for clinical trials should be extended to cpx',\n",
       " 'other antiviral drugs in pipeline may not be very useful as their productions and supplies to the developing countries may require lengthy timeframe whereas mass production of chloroquine and hydroxychloroquine is already in place in malaria endemic developing countries.',\n",
       " 'j o u r n a l p r e -p r o o f journal pre-proof',\n",
       " 'clinical presentation and pathology of covid-19 conclusion: the initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression.',\n",
       " 'hypertensive patients who received acei/arb therapy had a lower risk of developing severe pneumonia compared with those on non-acei/arb antihypertensive therapy, which suggested that acei/arb therapy may be protective from severe pulmonary injury for hypertensive patients.',\n",
       " 'however, these results should be interpreted with caution owing to potential bias and residual confounders in this observational study.',\n",
       " '39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.',\n",
       " 'by providing new information on molecules inhibiting sars-cov-2 replication in vitro, this study could contribute to the short-term repurposing of drugs against covid-19.',\n",
       " ' overall our results emphasize that the pk/pd properties of lopinavir/ritonavir, ifn-β-1a 194 and hydroxychloroquine make them unlikely to have a dramatic impact on viral load kinetics 195 in the nasopharynx if they are administered after symptom onset.',\n",
       " 'however, they may be relevant in pre-or post-exposure prophylaxis 202 administration to reduce viral replication and hence the risk of disease progression.',\n",
       " 'given the large existing manufacturing base and abundance of raw materials for hcq',\n",
       " ' meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19',\n",
       " ' excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology',\n",
       " 'our study suggests that drugs such as sqv and lpv have shown slightly higher, but comparative binding energies against the sars-cov-2, than hiv-1 protease.',\n",
       " 'these results evidence that these compounds could be suitable for further medicinal chemistry optimization to produce the second generation of inhibitors more specific and potent against sars-cov-2.',\n",
       " 'nevertheless, more pre-clinical and clinical data are required to support the development of new therapies against sars-cov-2.',\n",
       " ' remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro',\n",
       " ' expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia',\n",
       " 'we propose that the immunomodulatory effect of hydroxychloroquine also may be useful in controlling the cytokine storm that occurs late-phase in critically ill severe acute respiratory syndrome coronavirus 2 infected patients.',\n",
       " 'conclusions: hydroxychloroquine was found to be more potent than chloroquine to inhibit severe acute respiratory syndrome coronavirus 2',\n",
       " ' in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2',\n",
       " 'our study underlines the need to register as much details as possible on clinical trials registries during outbreaks in order to inform the development of future trials.',\n",
       " 'these results might inform the adaptation of existing clinical trials and the development of additional trials.',\n",
       " '16.20037135 doi: medrxiv preprint for ethical reasons and because our first results are so significant and evident we decide to share our findings with the medical community, given the urgent need for an effective drug against sars-cov-2 in the current pandemic context.',\n",
       " 'these results are of great importance because a recent paper has shown that the mean duration of viral shedding in patients suffering from covid-',\n",
       " 'however, its administration should be done under medical control to avo id potential side effects and to prevent an uncontrolled use leading to supply shortages.',\n",
       " 'j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof',\n",
       " 'indeed, our analysis suggests that inhaled ifn-α2b accelerated viral clearance from the respiratory tract and hastened resolution of systemic inflammatory processes when compared to arb treatment alone.',\n",
       " 'while we recognize that these data are at best suggestive, given the urgency, the findings indicate that a follow-up randomized placebo controlled clinical trial (rct the copyright holder for this preprint (which was not peer-reviewed) is the .',\n",
       " 'the results indicate that an ifn-α rct is now warranted.',\n",
       " 'the high mortality rate of this population suggests aggressive management is needed for kidney transplant patients with sars-cov2 infection, in particular early hospitalization should be considered in case of pneumonia; furthermore more effective treatment protocols need to be identified.',\n",
       " 'our study has limitations: the sample size is small and the median follow-up short; findings are, therefore, preliminary and will need to be confirmed in bigger cohorts with longer followup.',\n",
       " 'some strengths may be acknowledged as well and in particular the monocentric approach and the homogeneity of the clinical treatment employed.',\n",
       " ' case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?',\n",
       " 'journal pre-proof j o u r n a l p r e -p r o o f',\n",
       " 'most of the studies found in this article are scheduled to end in 2020, and we hope these repositioning trials may help to find solutions for covid-19 treatment by this year.',\n",
       " 'early supportive therapy should been provided to control disease progression and reduce the mortality of covid-19.',\n",
       " 'this map would be helpful for personalized medicine in the future.',\n",
       " 'moreover, ace2, the target of 2019-ncov, was only found in parts of lung cells, which makes drugs like chloroquine that prevent virus binding to ace2 more specific than other targeted drugs such as camostat mesylate.',\n",
       " 'third, this study was limited to the local investigation, and the findings may be inconsistent with nationwide or worldwide studies, which may decrease its credibility.',\n",
       " 'secondly, when the search space was expanded to all fda-approved drugs, some immunosuppressant drugs (rapamycin and everolimus) and a drug (tiotropium bromide) for asthma and chronic obstructive pulmonary disease (copd we hope our prediction results may support experimental therapeutic options for china and other countries suffering from the sars-cov-2 pandemic and align with recent clinical trials (35) .',\n",
       " 'we hope that our report will be helpful to stimulate pharmacovigilance and monitoring of adverse drug reactions with the use of cq or hcq',\n",
       " ' hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro']"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chloro_claim_sents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [],
   "source": [
    "def pair_sentences(sents, outpath):\n",
    "    \n",
    "    sent_pairs = []\n",
    "    \n",
    "    with open(outpath, 'w') as f:\n",
    "        for sent_i in sents:\n",
    "            for sent_j in sents:\n",
    "                f.write('%s\\t%s\\n' % (sent_i, sent_j))\n",
    "                sent_pairs.append((sent_i, sent_j))\n",
    "    \n",
    "    return sent_pairs\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [],
   "source": [
    "chloro_pairs = pair_sentences(chloro_sents, chloro_sents_outpath)\n",
    "chloro_claim_pairs = pair_sentences(chloro_claim_sents, chloro_claims_outpath)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\nRun pretrained MedNLI models on tab-separated sentence files here, and use output for following cells.\\n\\nEx command:\\n\\npython predict.py data/models/mednli.infersent.glovebioasqmimic.128.n8d0l13c.pkl data/chloro_claim_sents_200505.txt ../../resources/mednli/mednli_output/chloro_claim_sent_entail_glove_asq_mimic_200507.csv\\n\\n\\n'"
      ]
     },
     "execution_count": 106,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"\"\"\n",
    "Run pretrained MedNLI models on tab-separated sentence files here, and use output for following cells.\n",
    "\n",
    "Ex command:\n",
    "\n",
    "python predict.py data/models/mednli.infersent.glovebioasqmimic.128.n8d0l13c.pkl data/chloro_claim_sents_200505.txt ../../resources/mednli/mednli_output/chloro_claim_sent_entail_glove_asq_mimic_200507.csv\n",
    "\n",
    "\n",
    "\"\"\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [],
   "source": [
    "def format_scores_as_dict(sent_pairs, score_file):\n",
    "    \n",
    "    with open(score_file) as f:\n",
    "        scores = f.read().splitlines()\n",
    "        \n",
    "    sent_pair_score_tuples = list(zip(sent_pairs, scores[1:]))\n",
    "    \n",
    "    res_dict = {}\n",
    "    idx = 0\n",
    "    for sent_pair_score_tuple in sent_pair_score_tuples:\n",
    "        \n",
    "        score_res = sent_pair_score_tuple[1].split(',')\n",
    "\n",
    "        res_dict[idx] = {\n",
    "            'sent_1' : sent_pair_score_tuple[0][0],\n",
    "            'sent_2' : sent_pair_score_tuple[0][1],\n",
    "            'prediction' : score_res[0],\n",
    "            'contradiction' : score_res[1],\n",
    "            'entailment' : score_res[2],\n",
    "            'neutral' : score_res[3]\n",
    "        }\n",
    "        idx += 1\n",
    "    \n",
    "    return res_dict\n",
    "\n",
    "def convert_scores_dict_to_df(scores_dict, outpath):\n",
    "    \n",
    "    scores_df = pd.DataFrame.from_dict(scores_dict).transpose()\n",
    "    scores_df = scores_df[['sent_1', 'sent_2', 'prediction', 'contradiction', 'entailment', 'neutral']]\n",
    "    \n",
    "    scores_df.to_csv(outpath)\n",
    "    \n",
    "    return scores_df\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 136,
   "metadata": {},
   "outputs": [],
   "source": [
    "models = [\n",
    "    'glove',\n",
    "    'glovebioasqmimic'   \n",
    "]\n",
    "\n",
    "for model in models:\n",
    "    \n",
    "    chloro_results_outpath = '%s/chloro_sent_entail_%s_%s.csv' % (date_output_dir, model, timestr)\n",
    "    chloro_score_file = '%s/chloro_sent_score_%s_%s.csv' % (date_output_dir, model, timestr)\n",
    "    chloro_results_dict = format_scores_as_dict(chloro_pairs, chloro_score_file)\n",
    "    chloro_results_df = convert_scores_dict_to_df(chloro_results_dict, chloro_results_outpath)\n",
    "    \n",
    "    chloro_claim_results_outpath = '%s/chloro_claim_entail_%s_%s.csv' % (date_output_dir, model, timestr)\n",
    "    chloro_claim_score_file = '%s/chloro_claim_score_%s_%s.csv' % (date_output_dir, model, timestr)\n",
    "    chloro_claim_results_dict = format_scores_as_dict(chloro_claim_pairs, chloro_claim_score_file)\n",
    "    chloro_claims_df = convert_scores_dict_to_df(chloro_claim_results_dict, chloro_claim_results_outpath)\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "entailment       9310\n",
      "neutral          1788\n",
      "contradiction     351\n",
      "Name: prediction, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "Examining results\n",
    "\"\"\"\n",
    "\n",
    "\n",
    "category = 'contradiction'\n",
    "\n",
    "entail_df = pd.read_csv('../../../../resources/mednli/output/20200507/chloro_claim_entail_glovebioasqmimic_20200507.csv')\n",
    "contra_df = entail_df.loc[entail_df.prediction == category]\n",
    "\n",
    "print(entail_df.prediction.value_counts())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "\n",
      "\n",
      "this map would be helpful for personalized medicine in the future.\n",
      "0.99382\n",
      "\n",
      "\n",
      "hypertensive patients who received acei/arb therapy had a lower risk of developing severe pneumonia compared with those on non-acei/arb antihypertensive therapy, which suggested that acei/arb therapy may be protective from severe pulmonary injury for hypertensive patients.\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.99234\n",
      "\n",
      "\n",
      "these results can contribute to guide the design of new functional and high specific mabs providing a cost-and-time-effective computational framework towards the development of better diagnostic strategies and an effective treatment and/or vaccine for covid-19.\n",
      "\n",
      "\n",
      "we postulate here that the acidotropic and neutralization effects of azt, cpx and cq in normal cells would result in vectorially similar ph shifts away from optimal for the function of enzymes within the secretory pathway that would also alter glycosylation.\n",
      "0.99066\n",
      "\n",
      "\n",
      "these data also suggest further randomized-controlled studies of hcq-az combination therapy should be undertaken.\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.9872799999999999\n",
      "\n",
      "\n",
      "we propose that the drugs studied here, cq, azt and cpx, may modulate these aspects of host-pathogen interactions and virus infectious cycle, with immediate compassionate use in the clinic or in controlled clinical trials.\n",
      "\n",
      "\n",
      "this map would be helpful for personalized medicine in the future.\n",
      "0.98055\n",
      "\n",
      "\n",
      "finally, although baricitinib has the potential to affect sars-cov2 penetration into pulmonary epithelial cells, major concerns remain about the inhibition of ifns activity which could be detrimental in the course of viral infection.\n",
      "\n",
      "\n",
      "we postulate here that the acidotropic and neutralization effects of azt, cpx and cq in normal cells would result in vectorially similar ph shifts away from optimal for the function of enzymes within the secretory pathway that would also alter glycosylation.\n",
      "0.97929\n",
      "\n",
      "\n",
      "as the world awaits the results of clinical trials for the anti-viral efficacy of hcq in the treatment of sars-cov2 infection, this large scale, international real-world data network study enables us to consider the safety of the most popular drugs under consideration.\n",
      "\n",
      "\n",
      "we postulate here that the acidotropic and neutralization effects of azt, cpx and cq in normal cells would result in vectorially similar ph shifts away from optimal for the function of enzymes within the secretory pathway that would also alter glycosylation.\n",
      "0.9780700000000001\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "\n",
      "\n",
      " in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.9726\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.97159\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "\n",
      "\n",
      " case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "0.9708399999999999\n",
      "\n",
      "\n",
      "these results can contribute to guide the design of new functional and high specific mabs providing a cost-and-time-effective computational framework towards the development of better diagnostic strategies and an effective treatment and/or vaccine for covid-19.\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.9690700000000001\n",
      "\n",
      "\n",
      "hypertensive patients who received acei/arb therapy had a lower risk of developing severe pneumonia compared with those on non-acei/arb antihypertensive therapy, which suggested that acei/arb therapy may be protective from severe pulmonary injury for hypertensive patients.\n",
      "\n",
      "\n",
      "we postulate here that the acidotropic and neutralization effects of azt, cpx and cq in normal cells would result in vectorially similar ph shifts away from optimal for the function of enzymes within the secretory pathway that would also alter glycosylation.\n",
      "0.9635799999999999\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "\n",
      "\n",
      "this map would be helpful for personalized medicine in the future.\n",
      "0.9631700000000001\n",
      "\n",
      "\n",
      "our docking results show that remdesivir-tp binds to sars-cov-2 rdrp, with a score of -112.8, and the docking results are consistent with its original anti-viral mechanism, so we think remdesivir may be good in treating sars-cov-2 pneumonia.\n",
      "\n",
      "\n",
      "this map would be helpful for personalized medicine in the future.\n",
      "0.9613\n",
      "\n",
      "\n",
      "this would be the first successful use of cq in humans for treating acute viral disease.\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.95893\n",
      "\n",
      "\n",
      "in patients with covid-19, isolation for a minimum of 21 days after onset of illness may be warranted, while the use of antiviral drugs does not enhance viral rna clearance.\n",
      "\n",
      "\n",
      "hypertensive patients who received acei/arb therapy had a lower risk of developing severe pneumonia compared with those on non-acei/arb antihypertensive therapy, which suggested that acei/arb therapy may be protective from severe pulmonary injury for hypertensive patients.\n",
      "0.95365\n",
      "\n",
      "\n",
      "these data suggested that isolation for at least 21 days after the onset of symptom or first positive pcr test is warranted in both patients without or with improving symptoms.\n",
      "\n",
      "\n",
      "this map would be helpful for personalized medicine in the future.\n",
      "0.95258\n",
      "\n",
      "\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "\n",
      "\n",
      " meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.9518200000000001\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "\n",
      "\n",
      "we postulate here that the acidotropic and neutralization effects of azt, cpx and cq in normal cells would result in vectorially similar ph shifts away from optimal for the function of enzymes within the secretory pathway that would also alter glycosylation.\n",
      "0.94745\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for idx in range(1, 20):\n",
    "    print(contra_df.sort_values(by=category, ascending=False).iloc[idx]['sent_1'])\n",
    "    print('\\n')\n",
    "    print(contra_df.sort_values(by=category, ascending=False).iloc[idx]['sent_2'])\n",
    "    print(contra_df.sort_values(by=category, ascending=False).iloc[idx][category])\n",
    "    print('\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [],
   "source": [
    "chloro_contradictions_df = chloro_results_df.loc[chloro_results_df.prediction == 'contradiction']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.99838\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.99834\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.99796\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.99747\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.99746\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.99734\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.99675\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.99673\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.99630\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.99623\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.99568\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.99544\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.99515\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.99497\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.99453\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.99431\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.99420\n",
      "\n",
      "\n",
      "does hydroxychloroquine combat covid-19?\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.99377\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.99369\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.99340\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.99283\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.99282\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.99165\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.99087\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.99047\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.99041\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.99011\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.98987\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98981\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98966\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "of chloroquine and covid-19\n",
      "0.98956\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.98945\n",
      "\n",
      "\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.98914\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.98877\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.98868\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.98841\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.98748\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98734\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98731\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.98691\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.98689\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.98683\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.98669\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.98565\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.98507\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98462\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.98433\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.98411\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98395\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98348\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98318\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.98295\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "0.98157\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.98142\n",
      "\n",
      "\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.98109\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.98038\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.98013\n",
      "\n",
      "\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.97959\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.97855\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.97824\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "0.97740\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.97728\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.97663\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.97643\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.97625\n",
      "\n",
      "\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.97621\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.97592\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.97584\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.97544\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.97534\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.97411\n",
      "\n",
      "\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.97385\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.97354\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.97279\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.97260\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.97248\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.97120\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.97108\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.97092\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "0.97084\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.97073\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.97007\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.96894\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.96759\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.96719\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.96621\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.96574\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.96531\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.96500\n",
      "\n",
      "\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.96495\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.96475\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.96463\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.96397\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.96378\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.96376\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.96356\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.96347\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.96319\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.96309\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.96296\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.96263\n",
      "\n",
      "\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.96246\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.96209\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "0.96154\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.96091\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.96065\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.96055\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.96050\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.96038\n",
      "\n",
      "\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.95998\n",
      "\n",
      "\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.95949\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.95931\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.95867\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.95817\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.95761\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.95742\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.95739\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.95677\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.95606\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.95558\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.95524\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "0.95521\n",
      "\n",
      "\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.95334\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.95300\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "0.95212\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.95211\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.95182\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.94907\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.94901\n",
      "\n",
      "\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.94734\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "of chloroquine and covid-19\n",
      "0.94721\n",
      "\n",
      "\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.94717\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.94661\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.94607\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.94501\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.94498\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.94359\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.94347\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.94330\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.94306\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.94240\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.94120\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.94116\n",
      "\n",
      "\n",
      "the pharmaceutical interventions found for covid-19 treatment include human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, oseltamivir, favipiravir, carrimycin, methylprednisolone, bevacizumab, thalidomide, vitamin c, pirfenidone, bromhexine, fingolimod, danoprevir, ritonavir, darunavir, cobicistat, lopinavir, xiyanping, and traditional chinese medicines (tcm\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.94104\n",
      "\n",
      "\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.94099\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.94053\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.93987\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.93975\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.93972\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.93884\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.93847\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.93835\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.93800\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.93731\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.93698\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.93647\n",
      "\n",
      "\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.93628\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.93579\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.93575\n",
      "\n",
      "\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.93549\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.93498\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.93479\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.93478\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.93430\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.93400\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.93390\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.93383\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.93351\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.93333\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.93229\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.93221\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.93137\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.93110\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.93064\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.93054\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.93042\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.93030\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.92973\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.92969\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.92961\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.92897\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.92888\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.92879\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.92848\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.92842\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.92825\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.92807\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.92767\n",
      "\n",
      "\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.92706\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.92655\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.92568\n",
      "\n",
      "\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.92509\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.92478\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "0.92466\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.92412\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.92375\n",
      "\n",
      "\n",
      "objective: while there have been studies to describe the role of chloroquine and hydroxychloroquine in various viral conditions, there is limited information about the use of them in covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.92351\n",
      "\n",
      "\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.92340\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.92295\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.92295\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.92277\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "of chloroquine and covid-19\n",
      "0.92214\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.92121\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.92075\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.92063\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.92039\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "0.92028\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.92013\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.91983\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "0.91979\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.91906\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.91906\n",
      "\n",
      "\n",
      "chloroquine is newly recognized as potential effect against sars-cov. in our study, chloroquine was used to treat four (7.3%) patients, mostly used on overall, it needs to take a long time to identify or invent effective medicine for covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.91891\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "of chloroquine and covid-19\n",
      "0.91874\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.91846\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.91780\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.91717\n",
      "\n",
      "\n",
      "several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (covid-19\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.91711\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.91636\n",
      "\n",
      "\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.91515\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.91392\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "of chloroquine and covid-19\n",
      "0.91269\n",
      "\n",
      "\n",
      "two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.91207\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.91187\n",
      "\n",
      "\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.91179\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.91160\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.91130\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "0.91101\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.91024\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.91013\n",
      "\n",
      "\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.90996\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.90948\n",
      "\n",
      "\n",
      "clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.90932\n",
      "\n",
      "\n",
      "the cause of failure for hydroxychloroquine treatment should be investigated by testing the isolated sars-cov-2 strains of the non-respondents and analyzing their genome, and by analyzing the host factors that may be associated with the metabolism of hydroxychloroquine.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.90931\n",
      "\n",
      "\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.90916\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.90885\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.90742\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.90646\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.90548\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.90547\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.90418\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.90399\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.90387\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.90347\n",
      "\n",
      "\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.90285\n",
      "\n",
      "\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.90227\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.90196\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.90180\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.90119\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.90106\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.90075\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "0.90057\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.90027\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.89996\n",
      "\n",
      "\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.89976\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.89938\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.89879\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.89871\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.89799\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.89716\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.89679\n",
      "\n",
      "\n",
      "the cause of failure for hydroxychloroquine treatment should be investigated by testing the isolated sars-cov-2 strains of the non-respondents and analyzing their genome, and by analyzing the host factors that may be associated with the metabolism of hydroxychloroquine.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.89646\n",
      "\n",
      "\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.89582\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "of chloroquine and covid-19\n",
      "0.89571\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.89452\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.89452\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.89435\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "of chloroquine and covid-19\n",
      "0.89398\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.89398\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.89395\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.89376\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.89359\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.89342\n",
      "\n",
      "\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.89326\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.89311\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.89254\n",
      "\n",
      "\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.89194\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.89184\n",
      "\n",
      "\n",
      "moreover, ace2, the target of 2019-ncov, was only found in parts of lung cells, which makes drugs like chloroquine that prevent virus binding to ace2 more specific than other targeted drugs such as camostat mesylate.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.89138\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.89067\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.89038\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.89022\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.88981\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.88946\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "of chloroquine and covid-19\n",
      "0.88881\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.88713\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.88689\n",
      "\n",
      "\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.88674\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.88619\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.88595\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.88571\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.88480\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.88414\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.88375\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.88346\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.88113\n",
      "\n",
      "\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.88046\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.88031\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.88028\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.88018\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.88014\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.87982\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.87952\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.87923\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.87909\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.87899\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.87875\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.87854\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "0.87844\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.87804\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.87721\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "0.87682\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.87676\n",
      "\n",
      "\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.87666\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.87646\n",
      "\n",
      "\n",
      "recent studies suggest that hydroxychloroquine (hcq) could be effective against covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.87563\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.87452\n",
      "\n",
      "\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.87411\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.87408\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "of chloroquine and covid-19\n",
      "0.87403\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.87399\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "0.87390\n",
      "\n",
      "\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.87300\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.87238\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.87188\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.87102\n",
      "\n",
      "\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.87070\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.87062\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.87025\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.87012\n",
      "\n",
      "\n",
      "chloroquine is known to block virus infection by increasing endosomal ph required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of coronavirus, which has been confirmed to inhibit sars-cov-2 in vitro.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.87006\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "0.86936\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.86871\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.86866\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.86835\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.86781\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.86747\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.86737\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.86708\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.86703\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.86594\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.86564\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.86554\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.86513\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.86427\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.86422\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "of chloroquine and covid-19\n",
      "0.86396\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "0.86382\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.86327\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.86324\n",
      "\n",
      "\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.86252\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.86124\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.86113\n",
      "\n",
      "\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.86080\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.86068\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "of chloroquine and covid-19\n",
      "0.86044\n",
      "\n",
      "\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.85996\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.85992\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.85936\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.85885\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.85840\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.85831\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.85786\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.85776\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "0.85766\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "of chloroquine and covid-19\n",
      "0.85764\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.85651\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "0.85649\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.85487\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.85459\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.85445\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "0.85440\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.85437\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "of chloroquine and covid-19\n",
      "0.85422\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.85394\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.85338\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.85204\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.85160\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.85157\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.85154\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.85105\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.85100\n",
      "\n",
      "\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.85049\n",
      "\n",
      "\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.85032\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.85022\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "0.84955\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.84918\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.84848\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.84758\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.84730\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.84724\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.84722\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.84607\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.84606\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.84471\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "0.84431\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "0.84264\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.84211\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.84207\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.84196\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.84173\n",
      "\n",
      "\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.84124\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.84093\n",
      "\n",
      "\n",
      "the vital ethical issue is whether administration of chloroquine in the setting of covid-19 is experimental, and therefore requires ethical trial approval, or off-label (i.e. ethically justifiable as the best available treatment).\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.84061\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.83964\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.83957\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.83929\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.83891\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.83871\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.83865\n",
      "\n",
      "\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.83853\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.83848\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.83823\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.83785\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.83769\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.83696\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.83550\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.83542\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.83521\n",
      "\n",
      "\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.83508\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.83478\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.83426\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.83376\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.83343\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.83243\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.83229\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.83146\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "of chloroquine and covid-19\n",
      "0.83052\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "0.83049\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.83003\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.82985\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "0.82912\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.82880\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "of chloroquine and covid-19\n",
      "0.82781\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "0.82705\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.82630\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.82584\n",
      "\n",
      "\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.82562\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.82519\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.82445\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.82423\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.82367\n",
      "\n",
      "\n",
      "[23] [24] [25] regarding covid-19, a recent publication reported an activity of chloroquine on sars-cov-2 26 and another encouraged the use of chloroquine for patients with covid-19 on the basis of unreported clinical results.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.82360\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.82349\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.82286\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.82240\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.82190\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "of chloroquine and covid-19\n",
      "0.82143\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.82130\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.82058\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.82048\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.81942\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.81900\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.81868\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.81853\n",
      "\n",
      "\n",
      "other antivirals have been evaluated in sars-cov-2 as the polymerase inhibitor remdesivir, a nucleotide analog (currently in clinical trials against ebola virus and sars-cov-2), alone or in combination with chloroquine, an inhibitor of lysosome acidification, with interesting results (wang et al., 2020[18]; de wit et al., 2020[2]).\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.81833\n",
      "\n",
      "\n",
      "other antivirals have been evaluated in sars-cov-2 as the polymerase inhibitor remdesivir, a nucleotide analog (currently in clinical trials against ebola virus and sars-cov-2), alone or in combination with chloroquine, an inhibitor of lysosome acidification, with interesting results (wang et al., 2020[18]; de wit et al., 2020[2]).\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.81821\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.81607\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "of chloroquine and covid-19\n",
      "0.81605\n",
      "\n",
      "\n",
      "the cause of failure for hydroxychloroquine treatment should be investigated by testing the isolated sars-cov-2 strains of the non-respondents and analyzing their genome, and by analyzing the host factors that may be associated with the metabolism of hydroxychloroquine.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.81584\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.81558\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.81528\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.81396\n",
      "\n",
      "\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.81384\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.81372\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.81340\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.81336\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.81320\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.81314\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.81314\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "0.81260\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.81234\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.81157\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "0.81150\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.81107\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.81008\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.80988\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "the research letter, written by a group of chinese researchers, studied the effect of chloroquine in vitro, using vero e6 cells infected by sars-cov-2 at a multiplicity of infection (moi) of 0.05.\n",
      "0.80940\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.80922\n",
      "\n",
      "\n",
      "chloroquine seems to be effective in limiting the replication of sars-cov-2 (virus causing covid-19) in vitro.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.80858\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.80814\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.80795\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.80793\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.80786\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.80741\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.80726\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.80617\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "of chloroquine and covid-19\n",
      "0.80609\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.80595\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.80453\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.80431\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.80411\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.80355\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.80347\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "0.80293\n",
      "\n",
      "\n",
      "the cause of failure for hydroxychloroquine treatment should be investigated by testing the isolated sars-cov-2 strains of the non-respondents and analyzing their genome, and by analyzing the host factors that may be associated with the metabolism of hydroxychloroquine.\n",
      "of chloroquine and covid-19\n",
      "0.80274\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.80194\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.80132\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.80093\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "of chloroquine and covid-19\n",
      "0.80091\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.80077\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.80071\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "0.79981\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (covid-19\n",
      "0.79975\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.79946\n",
      "\n",
      "\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.79918\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "0.79864\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (covid-19\n",
      "0.79834\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.79787\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.79774\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.79680\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.79667\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.79635\n",
      "\n",
      "\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.79609\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.79599\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "0.79597\n",
      "\n",
      "\n",
      "chloroquine seems to be effective in limiting the replication of sars-cov-2 (virus causing covid-19) in vitro.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.79562\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.79547\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.79448\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.79436\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.79398\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "0.79357\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "0.79227\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.79200\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.79132\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.79130\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "0.79067\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "0.79065\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "of chloroquine and covid-19\n",
      "0.79057\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.79049\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.79011\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.78929\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.78928\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.78916\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.78902\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.78895\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.78806\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "of chloroquine and covid-19\n",
      "0.78772\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.78718\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.78673\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.78660\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.78607\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.78560\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.78516\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.78471\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.78469\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.78305\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.78225\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.78188\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.78183\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "of chloroquine and covid-19\n",
      "0.78163\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.78083\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.78036\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.78013\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.77914\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.77884\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.77882\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "the vital ethical issue is whether administration of chloroquine in the setting of covid-19 is experimental, and therefore requires ethical trial approval, or off-label (i.e. ethically justifiable as the best available treatment).\n",
      "0.77840\n",
      "\n",
      "\n",
      "the cause of failure for hydroxychloroquine treatment should be investigated by testing the isolated sars-cov-2 strains of the non-respondents and analyzing their genome, and by analyzing the host factors that may be associated with the metabolism of hydroxychloroquine.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.77828\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.77812\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "0.77792\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.77787\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.77702\n",
      "\n",
      "\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.77660\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.77599\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "0.77557\n",
      "\n",
      "\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.77534\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.77503\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.77495\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.77416\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.77407\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.77383\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.77313\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "hydroxychloroquine and ivermectin: a synergistic combination for covid-19 chemoprophylaxis and/or treatment?\n",
      "0.77268\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.77241\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.77041\n",
      "\n",
      "\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.77031\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "the vital ethical issue is whether administration of chloroquine in the setting of covid-19 is experimental, and therefore requires ethical trial approval, or off-label (i.e. ethically justifiable as the best available treatment).\n",
      "0.76993\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.76903\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.76890\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.76887\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.76873\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.76843\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "0.76723\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.76701\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.76687\n",
      "\n",
      "\n",
      "the pharmaceutical interventions found for covid-19 treatment include human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, oseltamivir, favipiravir, carrimycin, methylprednisolone, bevacizumab, thalidomide, vitamin c, pirfenidone, bromhexine, fingolimod, danoprevir, ritonavir, darunavir, cobicistat, lopinavir, xiyanping, and traditional chinese medicines (tcm\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.76599\n",
      "\n",
      "\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.76593\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "of chloroquine and covid-19\n",
      "0.76575\n",
      "\n",
      "\n",
      "chloroquine is known to block virus infection by increasing endosomal ph required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of coronavirus, which has been confirmed to inhibit sars-cov-2 in vitro.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.76543\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.76510\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.76510\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.76491\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.76468\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.76409\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.76395\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.76366\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.76363\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "of chloroquine and covid-19\n",
      "0.76348\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.76342\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.76296\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.76255\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.76193\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.76168\n",
      "\n",
      "\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.75999\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.75971\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "0.75936\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.75925\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.75852\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "of chloroquine and covid-19\n",
      "0.75851\n",
      "\n",
      "\n",
      "two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.75826\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.75820\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "of chloroquine and covid-19\n",
      "0.75799\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "0.75785\n",
      "\n",
      "\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.75677\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.75658\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.75615\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.75505\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.75464\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.75425\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.75338\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.75246\n",
      "\n",
      "\n",
      "chloroquine seems to be effective in limiting the replication of sars-cov-2 (virus causing covid-19) in vitro.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.75236\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.75176\n",
      "\n",
      "\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.75113\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.74941\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.74907\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.74899\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.74897\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "0.74896\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.74890\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.74855\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.74818\n",
      "\n",
      "\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.74786\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.74745\n",
      "\n",
      "\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.74739\n",
      "\n",
      "\n",
      "other antivirals have been evaluated in sars-cov-2 as the polymerase inhibitor remdesivir, a nucleotide analog (currently in clinical trials against ebola virus and sars-cov-2), alone or in combination with chloroquine, an inhibitor of lysosome acidification, with interesting results (wang et al., 2020[18]; de wit et al., 2020[2]).\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.74729\n",
      "\n",
      "\n",
      "hydroxychloroquine and ivermectin: a synergistic combination for covid-19 chemoprophylaxis and/or treatment?\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.74624\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.74513\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.74511\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.74485\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.74405\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.74391\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.74244\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.74157\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "0.74157\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.74122\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.74057\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.74045\n",
      "\n",
      "\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.74008\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.73829\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.73815\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "0.73745\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.73616\n",
      "\n",
      "\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.73603\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.73602\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.73594\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.73588\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.73566\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.73548\n",
      "\n",
      "\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.73536\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.73534\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.73523\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.73511\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.73505\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.73484\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.73466\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.73465\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.73314\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "0.73260\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.73259\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.73238\n",
      "\n",
      "\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.73195\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.73144\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "0.73114\n",
      "\n",
      "\n",
      "chloroquine is known to block virus infection by increasing endosomal ph required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of coronavirus, which has been confirmed to inhibit sars-cov-2 in vitro.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.73102\n",
      "\n",
      "\n",
      "hydroxychloroquine and ivermectin: a synergistic combination for covid-19 chemoprophylaxis and/or treatment?\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.73066\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "0.72991\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.72987\n",
      "\n",
      "\n",
      "[23] [24] [25] regarding covid-19, a recent publication reported an activity of chloroquine on sars-cov-2 26 and another encouraged the use of chloroquine for patients with covid-19 on the basis of unreported clinical results.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.72946\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.72927\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.72858\n",
      "\n",
      "\n",
      "moreover, ace2, the target of 2019-ncov, was only found in parts of lung cells, which makes drugs like chloroquine that prevent virus binding to ace2 more specific than other targeted drugs such as camostat mesylate.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.72838\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.72832\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.72830\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.72695\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "0.72630\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.72607\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.72603\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "0.72454\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.72423\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.72357\n",
      "\n",
      "\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.72344\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "0.72322\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.72304\n",
      "\n",
      "\n",
      "clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.72254\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.72212\n",
      "\n",
      "\n",
      "of chloroquine and covid-19\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.72157\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "of chloroquine and covid-19\n",
      "0.72146\n",
      "\n",
      "\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.72119\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.72036\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.72021\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.72012\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.71973\n",
      "\n",
      "\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.71963\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.71961\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "0.71898\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.71861\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.71811\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.71780\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.71696\n",
      "\n",
      "\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.71632\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.71631\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.71599\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.71539\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.71496\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.71485\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "of chloroquine and covid-19\n",
      "0.71473\n",
      "\n",
      "\n",
      "several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (covid-19\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.71469\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.71469\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.71446\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.71423\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "0.71412\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.71377\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.71334\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.71314\n",
      "\n",
      "\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.71290\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.71273\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.71244\n",
      "\n",
      "\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.71240\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.71120\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.71120\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "0.71088\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.71073\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.71073\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.71066\n",
      "\n",
      "\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.71044\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.71004\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.70992\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "0.70928\n",
      "\n",
      "\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.70902\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.70838\n",
      "\n",
      "\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.70816\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "0.70783\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.70743\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "0.70677\n",
      "\n",
      "\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.70660\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.70643\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.70609\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.70595\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "0.70493\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "0.70475\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.70474\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.70473\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.70471\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.70458\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.70418\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.70404\n",
      "\n",
      "\n",
      "clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study\n",
      "of chloroquine and covid-19\n",
      "0.70393\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.70371\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.70336\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.70333\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "0.70224\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "0.70200\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.70151\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.70126\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.70084\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "0.70083\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.70081\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.70062\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.69972\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.69950\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "0.69914\n",
      "\n",
      "\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.69827\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.69795\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.69776\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "0.69760\n",
      "\n",
      "\n",
      "conclusions: there is theoretical, experimental, preclinical and clinical evidence of the effectiveness of chloroquine in patients affected with covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.69744\n",
      "\n",
      "\n",
      "hydroxychloroquine and ivermectin: a synergistic combination for covid-19 chemoprophylaxis and/or treatment?\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.69704\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.69680\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.69609\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "0.69563\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.69535\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.69493\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "0.69443\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.69430\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.69344\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.69309\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.69263\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.69247\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.69209\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.69184\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "0.69184\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.69147\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.69127\n",
      "\n",
      "\n",
      "recent studies suggest that hydroxychloroquine (hcq) could be effective against covid-19.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.69119\n",
      "\n",
      "\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.69035\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.69000\n",
      "\n",
      "\n",
      "conclusions: there is theoretical, experimental, preclinical and clinical evidence of the effectiveness of chloroquine in patients affected with covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.68863\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.68854\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.68789\n",
      "\n",
      "\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.68730\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.68730\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.68662\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.68646\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.68551\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.68551\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.68531\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.68526\n",
      "\n",
      "\n",
      "other antivirals have been evaluated in sars-cov-2 as the polymerase inhibitor remdesivir, a nucleotide analog (currently in clinical trials against ebola virus and sars-cov-2), alone or in combination with chloroquine, an inhibitor of lysosome acidification, with interesting results (wang et al., 2020[18]; de wit et al., 2020[2]).\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.68511\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.68509\n",
      "\n",
      "\n",
      "does hydroxychloroquine combat covid-19?\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.68381\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.68365\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.68301\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.68275\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.68212\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.68178\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.68164\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.68147\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.68029\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.67936\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.67894\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.67752\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "0.67751\n",
      "\n",
      "\n",
      "[23] [24] [25] regarding covid-19, a recent publication reported an activity of chloroquine on sars-cov-2 26 and another encouraged the use of chloroquine for patients with covid-19 on the basis of unreported clinical results.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.67748\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.67746\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.67733\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "0.67660\n",
      "\n",
      "\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.67659\n",
      "\n",
      "\n",
      "comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.67658\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.67604\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.67602\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.67587\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.67419\n",
      "\n",
      "\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.67414\n",
      "\n",
      "\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.67373\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.67349\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.67305\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "0.67246\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "0.67144\n",
      "\n",
      "\n",
      "two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.67133\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.67128\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "0.67121\n",
      "\n",
      "\n",
      "clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.66985\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "of chloroquine and covid-19\n",
      "0.66983\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.66970\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.66947\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.66916\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.66914\n",
      "\n",
      "\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.66868\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.66844\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "0.66779\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.66731\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.66670\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "the cause of failure for hydroxychloroquine treatment should be investigated by testing the isolated sars-cov-2 strains of the non-respondents and analyzing their genome, and by analyzing the host factors that may be associated with the metabolism of hydroxychloroquine.\n",
      "0.66610\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.66556\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "0.66480\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.66411\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.66328\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.66230\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.66136\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.66080\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.65977\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "since sars-cov-2 was found a few days ago to utilise the same cell surface receptor ace2 (expressed in lung, heart, kidney and intestine) as sars-cov-1 [85 , 86] ( table 1 ) , it may be hypothesised that chloroquine also interferes with ace2 receptor glycosylation thus preventing sars-cov-2 binding to target cells.\n",
      "0.65914\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.65906\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "0.65897\n",
      "\n",
      "\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.65773\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "0.65702\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.65622\n",
      "\n",
      "\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.65616\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.65573\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.65560\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.65546\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "0.65468\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.65463\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.65422\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.65360\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "0.65322\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.65262\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.65232\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.65155\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.65133\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "0.65069\n",
      "\n",
      "\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.65068\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.65048\n",
      "\n",
      "\n",
      "does hydroxychloroquine combat covid-19?\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.65017\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.64996\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.64987\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.64945\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.64944\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.64926\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.64890\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.64773\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.64680\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.64652\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.64555\n",
      "\n",
      "\n",
      "clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.64456\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "0.64345\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.64340\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "of chloroquine and covid-19\n",
      "0.64263\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.64213\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.64144\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "0.64076\n",
      "\n",
      "\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.64070\n",
      "\n",
      "\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.64027\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.63921\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.63895\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "[12] a prominent national regulatory body has issued an advisory favouring prophylaxis with hydroxychloroquine for healthcare workers and close contacts of patients with covid-19 [13] however, caution is needed as reports of toxicity have emerged with the use of prophylaxis.\n",
      "0.63868\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.63695\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "of chloroquine and covid-19\n",
      "0.63685\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.63603\n",
      "\n",
      "\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "of chloroquine and covid-19\n",
      "0.63603\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "0.63577\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.63571\n",
      "\n",
      "\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.63569\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.63510\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "of chloroquine and covid-19\n",
      "0.63508\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.63499\n",
      "\n",
      "\n",
      "two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.63438\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.63436\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.63436\n",
      "\n",
      "\n",
      "two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.63434\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "0.63430\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.63424\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.63396\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.63324\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.63315\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "0.63310\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.63303\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.63246\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.63241\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.63169\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "0.63146\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (covid-19\n",
      "0.63032\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "0.63012\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.62988\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.62983\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.62974\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "0.62861\n",
      "\n",
      "\n",
      "results obtained from the recently conducted in vitro study against covid-19 are promising since the drugs remdesivir and chloroquine were found to be highly effective in controlling the infection.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.62857\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.62828\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "0.62806\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "0.62770\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.62766\n",
      "\n",
      "\n",
      "today, preliminary data indicate that chloroquine interferes with sars-cov-2 attempts to acidify the lysosomes and presumably inhibits cathepsins, which require a low ph for optimal cleavage of sars-cov-2 spike protein [89] , a prerequisite to the formation of the autophagosome [49] .\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.62698\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.62686\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.62682\n",
      "\n",
      "\n",
      "chloroquine is known to block virus infection by increasing endosomal ph required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of coronavirus, which has been confirmed to inhibit sars-cov-2 in vitro.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.62633\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.62575\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.62561\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "the research letter, written by a group of chinese researchers, studied the effect of chloroquine in vitro, using vero e6 cells infected by sars-cov-2 at a multiplicity of infection (moi) of 0.05.\n",
      "0.62554\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.62528\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.62503\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.62484\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.62479\n",
      "\n",
      "\n",
      "conclusions: there is theoretical, experimental, preclinical and clinical evidence of the effectiveness of chloroquine in patients affected with covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.62273\n",
      "\n",
      "\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.62130\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "0.62121\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.62097\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.62076\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.62075\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.62033\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.62002\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.61902\n",
      "\n",
      "\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.61882\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "0.61864\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "0.61844\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.61810\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.61810\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "0.61750\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.61644\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.61610\n",
      "\n",
      "\n",
      "the pharmaceutical interventions found for covid-19 treatment include human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, oseltamivir, favipiravir, carrimycin, methylprednisolone, bevacizumab, thalidomide, vitamin c, pirfenidone, bromhexine, fingolimod, danoprevir, ritonavir, darunavir, cobicistat, lopinavir, xiyanping, and traditional chinese medicines (tcm\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.61587\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.61586\n",
      "\n",
      "\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "of chloroquine and covid-19\n",
      "0.61572\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.61478\n",
      "\n",
      "\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.61438\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.61358\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.61357\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "0.61339\n",
      "\n",
      "\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.61306\n",
      "\n",
      "\n",
      "clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.61288\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.61230\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.61183\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.60964\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.60917\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "0.60904\n",
      "\n",
      "\n",
      "the pharmaceutical interventions found for covid-19 treatment include human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, oseltamivir, favipiravir, carrimycin, methylprednisolone, bevacizumab, thalidomide, vitamin c, pirfenidone, bromhexine, fingolimod, danoprevir, ritonavir, darunavir, cobicistat, lopinavir, xiyanping, and traditional chinese medicines (tcm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.60872\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.60837\n",
      "\n",
      "\n",
      "the research letter, written by a group of chinese researchers, studied the effect of chloroquine in vitro, using vero e6 cells infected by sars-cov-2 at a multiplicity of infection (moi) of 0.05.\n",
      "of chloroquine and covid-19\n",
      "0.60740\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.60733\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.60732\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "0.60692\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.60668\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.60631\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.60630\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.60586\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "0.60512\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.60502\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "0.60407\n",
      "\n",
      "\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "0.60403\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.60378\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.60374\n",
      "\n",
      "\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.60335\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.60308\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.60264\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.60250\n",
      "\n",
      "\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.60246\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.60229\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.60184\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.60128\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "[23] [24] [25] regarding covid-19, a recent publication reported an activity of chloroquine on sars-cov-2 26 and another encouraged the use of chloroquine for patients with covid-19 on the basis of unreported clinical results.\n",
      "0.60121\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.60023\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.59997\n",
      "\n",
      "\n",
      "recent studies suggest that hydroxychloroquine (hcq) could be effective against covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.59937\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.59824\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "0.59777\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.59746\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.59719\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.59710\n",
      "\n",
      "\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.59692\n",
      "\n",
      "\n",
      "hydroxychloroquine and ivermectin: a synergistic combination for covid-19 chemoprophylaxis and/or treatment?\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.59690\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.59675\n",
      "\n",
      "\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.59670\n",
      "\n",
      "\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.59593\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.59583\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.59574\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.59574\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.59568\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.59541\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.59463\n",
      "\n",
      "\n",
      "objective: while there have been studies to describe the role of chloroquine and hydroxychloroquine in various viral conditions, there is limited information about the use of them in covid-19.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.59452\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "0.59403\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.59361\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "0.59289\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.59284\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.59276\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.59178\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.59134\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.59089\n",
      "\n",
      "\n",
      "two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.59057\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.59043\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.58969\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.58909\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.58899\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "0.58889\n",
      "\n",
      "\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "of chloroquine and covid-19\n",
      "0.58886\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.58883\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.58814\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.58734\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.58733\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "0.58710\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.58687\n",
      "\n",
      "\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.58678\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.58646\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.58631\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "the vital ethical issue is whether administration of chloroquine in the setting of covid-19 is experimental, and therefore requires ethical trial approval, or off-label (i.e. ethically justifiable as the best available treatment).\n",
      "0.58600\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "0.58598\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.58462\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "0.58461\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "0.58420\n",
      "\n",
      "\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.58411\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.58410\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "0.58237\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "0.58226\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "0.58216\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.58195\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.58187\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.58148\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.58140\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.58056\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "0.58022\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.58021\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.58015\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "0.58003\n",
      "\n",
      "\n",
      "hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.57971\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.57919\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.57894\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.57889\n",
      "\n",
      "\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.57864\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "0.57857\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "0.57849\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "0.57848\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.57753\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.57544\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.57499\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.57467\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.57432\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "of chloroquine and covid-19\n",
      "0.57375\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.57358\n",
      "\n",
      "\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.57320\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "0.57283\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.57231\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.57216\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "0.57172\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.57169\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "the vital ethical issue is whether administration of chloroquine in the setting of covid-19 is experimental, and therefore requires ethical trial approval, or off-label (i.e. ethically justifiable as the best available treatment).\n",
      "0.57158\n",
      "\n",
      "\n",
      "objective: while there have been studies to describe the role of chloroquine and hydroxychloroquine in various viral conditions, there is limited information about the use of them in covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.57134\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "0.57132\n",
      "\n",
      "\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.57076\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.57066\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.57050\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "0.57029\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.56999\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.56999\n",
      "\n",
      "\n",
      "[23] [24] [25] regarding covid-19, a recent publication reported an activity of chloroquine on sars-cov-2 26 and another encouraged the use of chloroquine for patients with covid-19 on the basis of unreported clinical results.\n",
      "of chloroquine and covid-19\n",
      "0.56962\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "0.56862\n",
      "\n",
      "\n",
      "a number of nonspecific antiviral drugs, including ifn, lopinavir-ritonavir (hiv protease inhibitors), chloroquine, favipiravir (t-705) and remdesivir (gs-5734), have been used in clinics in china to treat sars-cov-2 infection.31 their in vivo efficacies still require further confirmation.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.56817\n",
      "\n",
      "\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "0.56796\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.56766\n",
      "\n",
      "\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.56717\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "0.56698\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.56673\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "0.56665\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.56520\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.56490\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.56488\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.56357\n",
      "\n",
      "\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.56302\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "0.56277\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "0.56238\n",
      "\n",
      "\n",
      "the pharmaceutical interventions found for covid-19 treatment include human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, oseltamivir, favipiravir, carrimycin, methylprednisolone, bevacizumab, thalidomide, vitamin c, pirfenidone, bromhexine, fingolimod, danoprevir, ritonavir, darunavir, cobicistat, lopinavir, xiyanping, and traditional chinese medicines (tcm\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.56230\n",
      "\n",
      "\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.56187\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.56180\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.56057\n",
      "\n",
      "\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.56056\n",
      "\n",
      "\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.56044\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.56006\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.55993\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.55959\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "0.55918\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.55903\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.55881\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.55835\n",
      "\n",
      "\n",
      "other antivirals have been evaluated in sars-cov-2 as the polymerase inhibitor remdesivir, a nucleotide analog (currently in clinical trials against ebola virus and sars-cov-2), alone or in combination with chloroquine, an inhibitor of lysosome acidification, with interesting results (wang et al., 2020[18]; de wit et al., 2020[2]).\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.55729\n",
      "\n",
      "\n",
      "safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for covid-19: a multinational, network cohort and self-controlled case series study\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.55698\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "0.55695\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.55694\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.55657\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "0.55653\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.55636\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.55619\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.55553\n",
      "\n",
      "\n",
      "chloroquine is known to block virus infection by increasing endosomal ph required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of coronavirus, which has been confirmed to inhibit sars-cov-2 in vitro.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.55520\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.55504\n",
      "\n",
      "\n",
      "several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (covid-19\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.55500\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "of chloroquine and covid-19\n",
      "0.55496\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.55469\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.55394\n",
      "\n",
      "\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "0.55264\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "of chloroquine and covid-19\n",
      "0.55219\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "hydroxychloroquine was the preferred choice (81.9%) for the treatment of covid-19 followed by protease inhibitors (22.1%) and intravenous immunoglobulin (8.1%).\n",
      "0.55180\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "of chloroquine and covid-19\n",
      "0.55114\n",
      "\n",
      "\n",
      "in the meantime, there is hope that a long-ago discovered antimalarial drug, hydroxychloroquine, may have lifesaving therapeutic efficacy against covid-19.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.55072\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "0.55071\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.55025\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.54919\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.54912\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.54910\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "0.54822\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.54800\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.54752\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.54722\n",
      "\n",
      "\n",
      "all the articles mentioned about the role of chloroquine and /or hydroxychloroquine in limiting the infection with sars-cov-2 (the virus causing covid-19).\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.54715\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.54714\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.54673\n",
      "\n",
      "\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.54627\n",
      "\n",
      "\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.54622\n",
      "\n",
      "\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.54593\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.54585\n",
      "\n",
      "\n",
      "the results of these trials will be the first available on humans, since studies published to date on the characteristics and management of patients with covid-19 did not report data about chloroquine use [1, [12] [13] [14] [15] .\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "0.54574\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.54531\n",
      "\n",
      "\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.54517\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.54469\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.54459\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "of chloroquine and covid-19\n",
      "0.54422\n",
      "\n",
      "\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "of chloroquine and covid-19\n",
      "0.54339\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.54312\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.54305\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.54279\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.54254\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "0.54210\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "0.54199\n",
      "\n",
      "\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.54136\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.54128\n",
      "\n",
      "\n",
      "other antivirals have been evaluated in sars-cov-2 as the polymerase inhibitor remdesivir, a nucleotide analog (currently in clinical trials against ebola virus and sars-cov-2), alone or in combination with chloroquine, an inhibitor of lysosome acidification, with interesting results (wang et al., 2020[18]; de wit et al., 2020[2]).\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.54126\n",
      "\n",
      "\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.54063\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.54056\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "in conclusion, chloroquine and hydroxchloroquine might have therapeutic potential for the medication of covid-19 in the current context of pandemic situation.\n",
      "0.54051\n",
      "\n",
      "\n",
      "the only viral disease where chloroquine was modestly effective so far before covid-19 era was chronic hepatitis c suggesting an increased virological response to pegylated interferon plus ribavirin [37] .\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.53979\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.53964\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "0.53944\n",
      "\n",
      "\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.53921\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.53917\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.53822\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.53793\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "chloroquine is newly recognized as potential effect against sars-cov. in our study, chloroquine was used to treat four (7.3%) patients, mostly used on overall, it needs to take a long time to identify or invent effective medicine for covid-19.\n",
      "0.53699\n",
      "\n",
      "\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.53657\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "0.53655\n",
      "\n",
      "\n",
      "[23] [24] [25] regarding covid-19, a recent publication reported an activity of chloroquine on sars-cov-2 26 and another encouraged the use of chloroquine for patients with covid-19 on the basis of unreported clinical results.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.53545\n",
      "\n",
      "\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.53516\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "0.53488\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.53463\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.53434\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.53374\n",
      "\n",
      "\n",
      "remdesivir and chloroquine are considered two promising agents for sars-cov-2 infection, 15 which were given to some patients in randomized, double-blind, placebo-controlled clinical trials.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.53356\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "0.53342\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.53304\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "lastly, azithromycin has shown promise in combination with chloroquine against sars-cov-2 (57) .\n",
      "0.53280\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "0.53278\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.53277\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.53271\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.53262\n",
      "\n",
      "\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.53209\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "0.53177\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "0.53103\n",
      "\n",
      "\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.53068\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "0.53027\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.52956\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "0.52954\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.52943\n",
      "\n",
      "\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.52901\n",
      "\n",
      "\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.52899\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "0.52877\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.52876\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.52828\n",
      "\n",
      "\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "0.52821\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.52812\n",
      "\n",
      "\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.52798\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "0.52761\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.52726\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.52698\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.52676\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.52674\n",
      "\n",
      "\n",
      "objectives: as of the early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 in the united states and in europe.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.52660\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.52639\n",
      "\n",
      "\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.52595\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.52586\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "0.52584\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "chloroquine and hydroxychloroquine have been found to be efficient on sars-cov-2, and reported to be efficient in chinese cov-19 patients.\n",
      "0.52572\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.52542\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "hydroxychloroquine and azithromycin on viral load in the upper respiratory tract of severe acute respiratory syndrome-coronavirus-2 (sars-cov-2) patients.\n",
      "0.52537\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.52533\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "of chloroquine and covid-19\n",
      "0.52515\n",
      "\n",
      "\n",
      "the research letter, written by a group of chinese researchers, studied the effect of chloroquine in vitro, using vero e6 cells infected by sars-cov-2 at a multiplicity of infection (moi) of 0.05.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.52476\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.52328\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.52324\n",
      "\n",
      "\n",
      "and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.52225\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.52220\n",
      "\n",
      "\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.52211\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "the vital ethical issue is whether administration of chloroquine in the setting of covid-19 is experimental, and therefore requires ethical trial approval, or off-label (i.e. ethically justifiable as the best available treatment).\n",
      "0.52195\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "indeed, several of the human proteins in the interactome are targeted by drugs that have emerged phenotypically as candidate therapeutics for treating covid-19, such as chloroquine 75, 76 .\n",
      "0.52124\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "0.52100\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.52084\n",
      "\n",
      "\n",
      "objective: while there have been studies to describe the role of chloroquine and hydroxychloroquine in various viral conditions, there is limited information about the use of them in covid-19.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.52059\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "of chloroquine and covid-19\n",
      "0.52030\n",
      "\n",
      "\n",
      "conclusions: there is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with covid-19.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.52029\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.51921\n",
      "\n",
      "\n",
      "these results are of great importance because a recent paper has shown that the mean duration of viral shedding in patients suffering from covid-19 in china was 20 days (even 37 days for the longest duration) [19] very recently, a chinese team published results of a study demonstrating that chloroquine and hydroxychloroquine inhibit sars-cov-2 in vitro with hydroxychloroquine (ec50=0.72%µm) found to be more potent than chloroquine (ec50=5.47%µm) [14] .\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.51912\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.51841\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "0.51783\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "quantifying treatment effects of hydroxychloroquine and azithromycin for covid-19: a secondary analysis of an open label non-randomized clinical trial (gautret et al, 2020)\n",
      "0.51751\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.51686\n",
      "\n",
      "\n",
      "27 experts in china have suggested the use of chloroquine for patients infected with sars-cov-2 but no clinical data has been provided yet to support this announcement.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.51674\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "0.51657\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.51651\n",
      "\n",
      "\n",
      "currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov. for this emergency, the fda has approved remdesivir and hydroxychloroquine for treatment of covid-19 as emergency use authorization.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.51644\n",
      "\n",
      "\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.51611\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "0.51608\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.51516\n",
      "\n",
      "\n",
      "there is sufficient pre-clinical rationale and evidence regarding the effectiveness of chloroquine for treatment of covid-19 as well as evidence of safety from long-time use in clinical practice for other indications [3] to justify clinical research on the topic.\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.51514\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "0.51490\n",
      "\n",
      "\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.51481\n",
      "\n",
      "\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "0.51465\n",
      "\n",
      "\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.51438\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "0.51432\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.51376\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "0.51329\n",
      "\n",
      "\n",
      "expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-ncov infection in vitro, while their cytotoxicity remains in control [22] .\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "0.51276\n",
      "\n",
      "\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: preliminary results of an open-label non-randomized clinical trial\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "0.51258\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "0.51251\n",
      "\n",
      "\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.51198\n",
      "\n",
      "\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.51198\n",
      "\n",
      "\n",
      "hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment for covid-19 infection.\n",
      "meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "0.51182\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.51159\n",
      "\n",
      "\n",
      "objective: while there have been studies to describe the role of chloroquine and hydroxychloroquine in various viral conditions, there is limited information about the use of them in covid-19.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.51117\n",
      "\n",
      "\n",
      "obviously, it can be hypothesised that sars-cov-2 molecular crosstalk with its target cell can be altered by chloroquine through inhibition of kinases such as mapk.\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "0.51082\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.51044\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.51037\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "to determine the relative impact of the use of chloroquine and hydroxychloroquine on outcomes important to patients with covid 19.\n",
      "0.51011\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine for the treatment of covid-19: a living systematic review protocol\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "0.50974\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "0.50947\n",
      "\n",
      "\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.50850\n",
      "\n",
      "\n",
      "recent studies suggest that hydroxychloroquine (hcq) could be effective against covid-19.\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.50770\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "0.50763\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.50753\n",
      "\n",
      "\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.50750\n",
      "\n",
      "\n",
      "therefore, the results of chloroquine and hcq so far done against covid-19, more promising than previous trial in other viral diseases.\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.50666\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "while malaria is endemic in poor parts of the world, the prevalence is still too less than the panic and feared caused by prevalence of covid-19 prompting pharmaceuticals for scaling up for the production of chloroquine.\n",
      "0.50620\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "0.50550\n",
      "\n",
      "\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "clinical trials on promising regimens for covid-19, such as remdesivir, lopinavir, and chloroquine phosphate are ongoing, which shed light on conquering the covid-19 epidemic 12 .\n",
      "0.50526\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "interestingly chloroquine has been shown to be effective in reduction of viral replications including covid-19.\n",
      "0.50468\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.50442\n",
      "\n",
      "\n",
      "chloroquine is known to block virus infection by increasing endosomal ph required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of coronavirus, which has been confirmed to inhibit sars-cov-2 in vitro.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.50415\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial\n",
      "0.50404\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.50404\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "efficacy of hydroxychloroquine in patients with covid-19: results of a randomized clinical trial\n",
      "0.50387\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "0.50369\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "0.50191\n",
      "\n",
      "\n",
      "based on in vitro evidence and still unpublished clinical experience, the panel recommended chloroquine phosphate tablet, at a dose of 500 mg twice per day for 10 days, for patients diagnosed as mild, moderate and severe cases of sars-cov-2 pneumonia, provided that there were no contraindications to the drug.\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.50078\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.50075\n",
      "\n",
      "\n",
      "chloroquine shows a potential antiviral effect in vitro, however, there is a lack of in vivo data to support therapeutic treatment for sars-cov-2 infection.\n",
      "while clinicians around the world are attempting to do this for the covid19 pandemic, the current approaches have been haphazard, which have resulted in equivocal results regarding drug efficacies and possible toxicity risks as in the case of chloroquine 1-3 ; thus, there is a great need to attack this problem in a author/funder.\n",
      "0.50067\n",
      "\n",
      "\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.50063\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine are currently included in the treatment protocol for the management of covid-19 infections and might be useful to prevent or mitigate the course of infection in patients with ra taking them as csdmards.\n",
      "of chloroquine and covid-19\n",
      "0.50049\n",
      "\n",
      "\n",
      "the pharmaceutical interventions found for covid-19 treatment include human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, oseltamivir, favipiravir, carrimycin, methylprednisolone, bevacizumab, thalidomide, vitamin c, pirfenidone, bromhexine, fingolimod, danoprevir, ritonavir, darunavir, cobicistat, lopinavir, xiyanping, and traditional chinese medicines (tcm\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "0.50048\n",
      "\n",
      "\n",
      "we will include randomised controlled trials evaluating the effect of chloroquine and hydroxychloroquine -as monotherapy or in combination with other drugs -versus placebo or no treatment in patients with covid-19.\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "0.50003\n",
      "\n",
      "\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "methods: pubmed, embase, and three trial registries were searched for studies on the use of chloroquine in patients with covid-19.\n",
      "0.50002\n",
      "\n",
      "\n",
      "french confirmed covid-19 patients were included in a single arm protocol from early march to march 16 th , to receive 600mg of hydroxychloroquine daily and their viral load in nasopharyngeal swabs was tested daily in a hospital setting.\n",
      "a bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with covid-19\n",
      "0.50002\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine in the treatment of covid-19 with or without diabetes:\n",
      "of chloroquine and covid-19\n",
      "0.49971\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "due to the low cost, easy accessibility, and lack of alternative treatment options, treatment with a combination of hydroxychloroquine and azithromycin is often considered for hospitalized patients with moderate to severe covid-19.\n",
      "0.49967\n",
      "\n",
      "\n",
      "raoult d, clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study, travel medicine and infectious disease (2020), doi: https://doi.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.49966\n",
      "\n",
      "\n",
      "besides, chloroquine phosphate was reported to have apparent efficacy and acceptable safety against covid-19 in a multicenter clinical trials 21 and had just been included in the latest edition of the guidelines for china.\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "0.49947\n",
      "\n",
      "\n",
      "role of chloroquine and hydroxychloroquine in the treatment of covid-19 infection- a systematic literature review\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.49921\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.49845\n",
      "\n",
      "\n",
      "another well-known candidate that is being evaluated in multiple trials against covid-19 is chloroquine (or hydroxychloroquine), which is already approved as an antimalarial (and for extraintestinal amebiasis) [41,48].\n",
      "in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "0.49780\n",
      "\n",
      "\n",
      "in this review, we found 24 clinical trials that have already started with the repositioning of more than 20 medicines for covid-19 treatment, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, oseltamivir, thalidomide, methylprednisolone, bevacizumab, and tcm.\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.49765\n",
      "\n",
      "\n",
      "a systematic review on the efficacy and safety of chloroquine for the treatment of covid-19\n",
      "of chloroquine and covid-19\n",
      "0.49745\n",
      "\n",
      "\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.49339\n",
      "\n",
      "\n",
      "coalition: advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against covid-19\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.49336\n",
      "\n",
      "\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "for example, remdesivir and chloroquine showed inhibitory effects against sars-cov-2 in vitro (31) .\n",
      "0.48929\n",
      "\n",
      "\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "0.48793\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the covid-19 pandemic.\n",
      "0.48686\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "0.48631\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "another in-vitro study showed that hydroxychloroquine was found to be more potent than chloroquine for inhibiting sars-cov-2 (32).\n",
      "0.48189\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.48165\n",
      "\n",
      "\n",
      "chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (sars-cov-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study)\n",
      "since sars-cov-2 was found a few days ago to utilise the same cell surface receptor ace2 (expressed in lung, heart, kidney and intestine) as sars-cov-1 [85 , 86] ( table 1 ) , it may be hypothesised that chloroquine also interferes with ace2 receptor glycosylation thus preventing sars-cov-2 binding to target cells.\n",
      "0.48148\n",
      "\n",
      "\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "0.48019\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.47981\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.47896\n",
      "\n",
      "\n",
      "remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.47755\n",
      "\n",
      "\n",
      "does hydroxychloroquine combat covid-19?\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "0.47608\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "a narrative letter by chinese authors reported that a news briefing from the state council of china had indicated that \"chloroquine phos-phate… had demonstrated marked efficacy and acceptable safety in treating covid-19 associated pneumonia in multicentre clinical trials conducted in china\" [5] .\n",
      "0.47542\n",
      "\n",
      "\n",
      "hydroxychloroquine and ivermectin: a synergistic combination for covid-19 chemoprophylaxis and/or treatment?\n",
      "of chloroquine and covid-19\n",
      "0.47477\n",
      "\n",
      "\n",
      "it is possible that chloroquine interferes with ace2 receptor glycosylation, thus preventing sars-cov-2 binding to target cells.\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "0.47313\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.46973\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.46912\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.46573\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "0.46572\n",
      "\n",
      "\n",
      "rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for covid-19\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.46351\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "0.45865\n",
      "\n",
      "\n",
      "randomised trials evaluating chloroquine and hydroxychloroquine in infections caused by other coronaviruses, such as mers-cov and sars-cov, and non-randomised studies in covid-19 will be searched in case no direct evidence from randomised trials is found, or if the direct evidence provides low-or very low-certainty for critical outcomes.\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.45816\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.45444\n",
      "\n",
      "\n",
      "no evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for covid-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial\n",
      "interestingly, chloroquine, one of the drugs being currently used against covid-19, is also known to bind to a methyltransferase [23] , the histamine n-methyltransferase (hnmt).\n",
      "0.45022\n",
      "\n",
      "\n",
      "no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.44997\n",
      "\n",
      "\n",
      "search terms were, covid-19, treatment of coronavirus, covid 19 and following terms; chloroquine, hydroxychloroquine, ibuprofen, ace-inhibitors or angiotensin receptor blockers, cardiovascular disease, diarrhoea, liver, testis and gastrointestinal disease.\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.44752\n",
      "\n",
      "\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.44717\n",
      "\n",
      "\n",
      "chloroquine as prophylactic agent against covid-19?\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.44616\n",
      "\n",
      "\n",
      "conclusions: there is theoretical, experimental, preclinical and clinical evidence of the effectiveness of chloroquine in patients affected with covid-19.\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.44251\n",
      "\n",
      "\n",
      "caution and clarity required in the use of chloroquine for covid-19\n",
      "hydroxychloroquine in patients with covid-19: an open-label, randomized, controlled trial\n",
      "0.44045\n",
      "\n",
      "\n",
      "therapeutic application of chloroquine in clinical trials for covid-19\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.43680\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "chloroquine phosphate and hydroxychloroquine were reported in this review and showed favorable outcomes on the recovery of covid-19 patients (6) (7) (57) (58) (59) (60) .\n",
      "0.43240\n",
      "\n",
      "\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "0.43082\n",
      "\n",
      "\n",
      "hydroxychloroquine is being used globally for treatment and prophylaxis of covid-19.\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.42583\n",
      "\n",
      "\n",
      "excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "we reviewed all interventional covid-19 trials on remdesivir, lopinavir/ritonavir and hydroxychloroquine registered in the national library of medicine (nlm) at the national institutes of health (nih\n",
      "0.42541\n",
      "\n",
      "\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "0.42317\n",
      "\n",
      "\n",
      "cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of covid-19 patients:\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "0.42040\n",
      "\n",
      "\n",
      "clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 covid-19 patients with at least a six-day follow up: a pilot observational study\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.41899\n",
      "\n",
      "\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "some covid-19 patients are responding well to chloroquine whereas others are not.\n",
      "0.40953\n",
      "\n",
      "\n",
      "breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.40114\n",
      "\n",
      "\n",
      "the aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of covid-19.\n",
      "this issue has rapidly reviewed and published articles describing covid-19, including the drug treatment options for sars-cov-2, its clinical characteristics, and therapies involving a combination of chinese and western medicine, the efficacy of chloroquine phosphate in the treatment of covid-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies.\n",
      "0.39299\n",
      "\n",
      "\n",
      "aminoquinolines against coronavirus disease 2019 (covid-19): chloroquine or hydroxychloroquine\n",
      "although the binding of sars-cov to sialic acids has not been reported so far (it is expected that betacoronavirus adaptation to humans involves progressive loss of hemagglutinin-esterase lectin activity), if sars-cov-2 like other coronaviruses targets sialic acids on some cell subtypes, this interaction will be affected by chloroquine treatment [87 , 88] .\n",
      "0.38909\n",
      "\n",
      "\n",
      "although the use of chloroquine may be supported by expert opinion, clinical use of this drug in patients with covid-19 should adhere to the meuri framework or after ethical approval as a trial as stated by the who.\n",
      "background hydroxychloroquine has recently received emergency use authorization by the fda and is currently prescribed in combination with azithromycin for covid-19 pneumonia.\n",
      "0.38809\n",
      "\n",
      "\n",
      "chloroquine and hydroxychloroquine as available weapons to fight covid-19\n",
      "evaluating the potentially favorable benefit-risk balance, without any choice of valid therapeutic options left, chloroquine and hydroxychloroquine could be applicable for the management of covid-19 in the present context of outbreak, however the respective national guidelines and clinician's evaluation and decision is recommended.\n",
      "0.38746\n",
      "\n",
      "\n",
      "recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by sars-cov-2.\n",
      "gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al.2020).\n",
      "0.38159\n",
      "\n",
      "\n",
      "although evidence of chloroquine and hcq is limited (based on the experimental data and only two small human trials), considering the potentially favorable benefit-risk balance of chloroquine and hcq in absence of any other valid treatment option, we believe that such treatment could be useful in the current context of pandemic covid-19 outbreak.\n",
      "chloroquine for the 2019 novel coronavirus sars-cov-2\n",
      "0.37895\n",
      "\n",
      "\n",
      "although both flu and anti-hiv drugs are used currently in china for treatment of covid-19, and chloroquine phosphate, an old drug for treatment of malaria, has recently found to have apparent efficacy and acceptable safety against 79] ; nevertheless more studies are required to standardize these therapies.\n",
      "of chloroquine and covid-19\n",
      "0.37445\n",
      "\n",
      "\n",
      "structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against sars-cov-2 infection\n",
      "does hydroxychloroquine combat covid-19?\n",
      "0.36597\n",
      "\n",
      "\n",
      "[36] [37] [38] a recent open label non randomized clinical trial reported that hydroxychloroquine combined with azithromycin is significantly associated with viral load reduction/disappearance in covid-19 patients.\n",
      "use of hydroxychloroquine and chloroquine during the covid-19 pandemic:\n",
      "0.34825\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for idx, row in chloro_contradictions_df.sort_values(by='contradiction', ascending=False).iterrows():\n",
    "    ,\n",
    "    print(row.sent_1)\n",
    "    print(row.sent_2)\n",
    "    print(row.contradiction)\n",
    "     \n",
    "    #print(chloro_results_df.loc[chloro_results_df.sent_1 == row.sent_2].loc[chloro_results_df.sent_2 == row.sent_1])\n",
    "    print('\\n')\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_sent = 'no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_df = chloro_results_df.loc[chloro_results_df.sent_2 == test_sent]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sent_1</th>\n",
       "      <th>sent_2</th>\n",
       "      <th>prediction</th>\n",
       "      <th>contradiction</th>\n",
       "      <th>entailment</th>\n",
       "      <th>neutral</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>730</th>\n",
       "      <td>two medications often used for treatment of im...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.79144</td>\n",
       "      <td>0.20855</td>\n",
       "      <td>0.00001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9507</th>\n",
       "      <td>the pharmaceutical interventions found for cov...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.75227</td>\n",
       "      <td>0.24766</td>\n",
       "      <td>0.00006</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>rapid reporting and dissemination of results a...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.68502</td>\n",
       "      <td>0.31487</td>\n",
       "      <td>0.00011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12651</th>\n",
       "      <td>recent studies suggest that hydroxychloroquine...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.66036</td>\n",
       "      <td>0.33917</td>\n",
       "      <td>0.00047</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4136</th>\n",
       "      <td>therapeutic application of chloroquine in clin...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.64726</td>\n",
       "      <td>0.35263</td>\n",
       "      <td>0.00010</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13175</th>\n",
       "      <td>several drugs such as chloroquine, arbidol, re...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.62030</td>\n",
       "      <td>0.37968</td>\n",
       "      <td>0.00002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15402</th>\n",
       "      <td>of chloroquine and covid-19</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.58796</td>\n",
       "      <td>0.40958</td>\n",
       "      <td>0.00246</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1385</th>\n",
       "      <td>caution and clarity required in the use of chl...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.57954</td>\n",
       "      <td>0.41988</td>\n",
       "      <td>0.00058</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11734</th>\n",
       "      <td>hydroxychloroquine is being used globally for ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>contradiction</td>\n",
       "      <td>0.57592</td>\n",
       "      <td>0.42383</td>\n",
       "      <td>0.00024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2040</th>\n",
       "      <td>case report of chloroquine therapy and hypogly...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.49828</td>\n",
       "      <td>0.50165</td>\n",
       "      <td>0.00007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11603</th>\n",
       "      <td>cardiovascular risks of hydroxychloroquine in ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.48273</td>\n",
       "      <td>0.51630</td>\n",
       "      <td>0.00097</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14354</th>\n",
       "      <td>these results provide information that can be ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.43519</td>\n",
       "      <td>0.56382</td>\n",
       "      <td>0.00099</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2564</th>\n",
       "      <td>although both flu and anti-hiv drugs are used ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.42379</td>\n",
       "      <td>0.57617</td>\n",
       "      <td>0.00004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4398</th>\n",
       "      <td>in conclusion, chloroquine and hydroxchloroqui...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.42174</td>\n",
       "      <td>0.57822</td>\n",
       "      <td>0.00004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1123</th>\n",
       "      <td>meeting the potential emergency global drug su...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.41992</td>\n",
       "      <td>0.57986</td>\n",
       "      <td>0.00023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10555</th>\n",
       "      <td>french confirmed covid-19 patients were includ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.36987</td>\n",
       "      <td>0.63009</td>\n",
       "      <td>0.00004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9376</th>\n",
       "      <td>a number of nonspecific antiviral drugs, inclu...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.36649</td>\n",
       "      <td>0.63347</td>\n",
       "      <td>0.00004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3219</th>\n",
       "      <td>we show here that hydroxychloroquine is effici...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.35376</td>\n",
       "      <td>0.64554</td>\n",
       "      <td>0.00070</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2957</th>\n",
       "      <td>besides, chloroquine phosphate was reported to...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.34967</td>\n",
       "      <td>0.64980</td>\n",
       "      <td>0.00053</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9638</th>\n",
       "      <td>in this review, we found 24 clinical trials th...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.33950</td>\n",
       "      <td>0.66048</td>\n",
       "      <td>0.00002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16057</th>\n",
       "      <td>conclusions: there is rationale, pre-clinical ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.33198</td>\n",
       "      <td>0.66795</td>\n",
       "      <td>0.00007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9245</th>\n",
       "      <td>chloroquine and hydroxychloroquine as availabl...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.31237</td>\n",
       "      <td>0.68636</td>\n",
       "      <td>0.00127</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>599</th>\n",
       "      <td>use of hydroxychloroquine and chloroquine duri...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.30684</td>\n",
       "      <td>0.69248</td>\n",
       "      <td>0.00067</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10817</th>\n",
       "      <td>we show here that hydroxychloroquine is effici...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.30450</td>\n",
       "      <td>0.69493</td>\n",
       "      <td>0.00057</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>another well-known candidate that is being eva...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.30160</td>\n",
       "      <td>0.69765</td>\n",
       "      <td>0.00075</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3350</th>\n",
       "      <td>[23] [24] [25] regarding covid-19, a recent pu...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.29411</td>\n",
       "      <td>0.70542</td>\n",
       "      <td>0.00047</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5184</th>\n",
       "      <td>conclusions: there is theoretical, experimenta...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.29304</td>\n",
       "      <td>0.70680</td>\n",
       "      <td>0.00016</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10424</th>\n",
       "      <td>chloroquine and hydroxychloroquine have been f...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.27600</td>\n",
       "      <td>0.72319</td>\n",
       "      <td>0.00082</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6494</th>\n",
       "      <td>to determine the relative impact of the use of...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.27590</td>\n",
       "      <td>0.72374</td>\n",
       "      <td>0.00035</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2695</th>\n",
       "      <td>clinical trials on promising regimens for covi...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.27434</td>\n",
       "      <td>0.72546</td>\n",
       "      <td>0.00020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4529</th>\n",
       "      <td>while malaria is endemic in poor parts of the ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.04441</td>\n",
       "      <td>0.95551</td>\n",
       "      <td>0.00008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10948</th>\n",
       "      <td>these results are of great importance because ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.04295</td>\n",
       "      <td>0.95680</td>\n",
       "      <td>0.00025</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7542</th>\n",
       "      <td>[36] [37] [38] a recent open label non randomi...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.04283</td>\n",
       "      <td>0.95714</td>\n",
       "      <td>0.00003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10031</th>\n",
       "      <td>due to the low cost, easy accessibility, and l...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.04115</td>\n",
       "      <td>0.95883</td>\n",
       "      <td>0.00002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13699</th>\n",
       "      <td>chloroquine shows a potential antiviral effect...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.04004</td>\n",
       "      <td>0.95993</td>\n",
       "      <td>0.00003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15009</th>\n",
       "      <td>does hydroxychloroquine combat covid-19?</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.03267</td>\n",
       "      <td>0.96528</td>\n",
       "      <td>0.00205</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7018</th>\n",
       "      <td>chloroquine diphosphate in two different dosag...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.03067</td>\n",
       "      <td>0.96929</td>\n",
       "      <td>0.00004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9769</th>\n",
       "      <td>results obtained from the recently conducted i...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.02819</td>\n",
       "      <td>0.97179</td>\n",
       "      <td>0.00002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4791</th>\n",
       "      <td>role of chloroquine and hydroxychloroquine in ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01997</td>\n",
       "      <td>0.97959</td>\n",
       "      <td>0.00043</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10162</th>\n",
       "      <td>aminoquinolines against coronavirus disease 20...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01717</td>\n",
       "      <td>0.98203</td>\n",
       "      <td>0.00080</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6625</th>\n",
       "      <td>we will include randomised controlled trials e...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01656</td>\n",
       "      <td>0.98333</td>\n",
       "      <td>0.00011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1516</th>\n",
       "      <td>the only viral disease where chloroquine was m...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01537</td>\n",
       "      <td>0.98452</td>\n",
       "      <td>0.00010</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15533</th>\n",
       "      <td>a systematic review on the efficacy and safety...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01530</td>\n",
       "      <td>0.98446</td>\n",
       "      <td>0.00024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6101</th>\n",
       "      <td>hydroxychloroquine was the preferred choice (8...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01483</td>\n",
       "      <td>0.98503</td>\n",
       "      <td>0.00014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>861</th>\n",
       "      <td>chloroquine and hydroxychloroquine in the trea...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01152</td>\n",
       "      <td>0.98801</td>\n",
       "      <td>0.00047</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12389</th>\n",
       "      <td>this issue has rapidly reviewed and published ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.01006</td>\n",
       "      <td>0.98992</td>\n",
       "      <td>0.00002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16319</th>\n",
       "      <td>a narrative letter by chinese authors reported...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00928</td>\n",
       "      <td>0.99058</td>\n",
       "      <td>0.00014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13044</th>\n",
       "      <td>breakthrough: chloroquine phosphate has shown ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00723</td>\n",
       "      <td>0.99272</td>\n",
       "      <td>0.00005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6363</th>\n",
       "      <td>chloroquine and hydroxychloroquine for the tre...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00718</td>\n",
       "      <td>0.99257</td>\n",
       "      <td>0.00025</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8197</th>\n",
       "      <td>although the binding of sars-cov to sialic aci...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00619</td>\n",
       "      <td>0.99302</td>\n",
       "      <td>0.00079</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10686</th>\n",
       "      <td>despite its small sample size our survey shows...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00440</td>\n",
       "      <td>0.99557</td>\n",
       "      <td>0.00003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5970</th>\n",
       "      <td>chloroquine phosphate and hydroxychloroquine w...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00359</td>\n",
       "      <td>0.99623</td>\n",
       "      <td>0.00019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16450</th>\n",
       "      <td>based on in vitro evidence and still unpublish...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00337</td>\n",
       "      <td>0.99663</td>\n",
       "      <td>0.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3481</th>\n",
       "      <td>27 experts in china have suggested the use of ...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00232</td>\n",
       "      <td>0.99752</td>\n",
       "      <td>0.00016</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14223</th>\n",
       "      <td>conclusion: current pharmacovigilance study re...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00200</td>\n",
       "      <td>0.99795</td>\n",
       "      <td>0.00004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4267</th>\n",
       "      <td>evaluating the potentially favorable benefit-r...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00106</td>\n",
       "      <td>0.99886</td>\n",
       "      <td>0.00009</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1254</th>\n",
       "      <td>currently, there is no vaccine or specific dru...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00070</td>\n",
       "      <td>0.99927</td>\n",
       "      <td>0.00003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6756</th>\n",
       "      <td>randomised trials evaluating chloroquine and h...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00061</td>\n",
       "      <td>0.99932</td>\n",
       "      <td>0.00008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13961</th>\n",
       "      <td>no evidence of clinical efficacy of hydroxychl...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00020</td>\n",
       "      <td>0.99980</td>\n",
       "      <td>0.00001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9900</th>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>no evidence of rapid antiviral clearance or cl...</td>\n",
       "      <td>entailment</td>\n",
       "      <td>0.00017</td>\n",
       "      <td>0.99983</td>\n",
       "      <td>0.00000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>131 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  sent_1  \\\n",
       "730    two medications often used for treatment of im...   \n",
       "9507   the pharmaceutical interventions found for cov...   \n",
       "337    rapid reporting and dissemination of results a...   \n",
       "12651  recent studies suggest that hydroxychloroquine...   \n",
       "4136   therapeutic application of chloroquine in clin...   \n",
       "13175  several drugs such as chloroquine, arbidol, re...   \n",
       "15402                        of chloroquine and covid-19   \n",
       "1385   caution and clarity required in the use of chl...   \n",
       "11734  hydroxychloroquine is being used globally for ...   \n",
       "2040   case report of chloroquine therapy and hypogly...   \n",
       "11603  cardiovascular risks of hydroxychloroquine in ...   \n",
       "14354  these results provide information that can be ...   \n",
       "2564   although both flu and anti-hiv drugs are used ...   \n",
       "4398   in conclusion, chloroquine and hydroxchloroqui...   \n",
       "1123   meeting the potential emergency global drug su...   \n",
       "10555  french confirmed covid-19 patients were includ...   \n",
       "9376   a number of nonspecific antiviral drugs, inclu...   \n",
       "3219   we show here that hydroxychloroquine is effici...   \n",
       "2957   besides, chloroquine phosphate was reported to...   \n",
       "9638   in this review, we found 24 clinical trials th...   \n",
       "16057  conclusions: there is rationale, pre-clinical ...   \n",
       "9245   chloroquine and hydroxychloroquine as availabl...   \n",
       "599    use of hydroxychloroquine and chloroquine duri...   \n",
       "10817  we show here that hydroxychloroquine is effici...   \n",
       "75     another well-known candidate that is being eva...   \n",
       "3350   [23] [24] [25] regarding covid-19, a recent pu...   \n",
       "5184   conclusions: there is theoretical, experimenta...   \n",
       "10424  chloroquine and hydroxychloroquine have been f...   \n",
       "6494   to determine the relative impact of the use of...   \n",
       "2695   clinical trials on promising regimens for covi...   \n",
       "...                                                  ...   \n",
       "4529   while malaria is endemic in poor parts of the ...   \n",
       "10948  these results are of great importance because ...   \n",
       "7542   [36] [37] [38] a recent open label non randomi...   \n",
       "10031  due to the low cost, easy accessibility, and l...   \n",
       "13699  chloroquine shows a potential antiviral effect...   \n",
       "15009           does hydroxychloroquine combat covid-19?   \n",
       "7018   chloroquine diphosphate in two different dosag...   \n",
       "9769   results obtained from the recently conducted i...   \n",
       "4791   role of chloroquine and hydroxychloroquine in ...   \n",
       "10162  aminoquinolines against coronavirus disease 20...   \n",
       "6625   we will include randomised controlled trials e...   \n",
       "1516   the only viral disease where chloroquine was m...   \n",
       "15533  a systematic review on the efficacy and safety...   \n",
       "6101   hydroxychloroquine was the preferred choice (8...   \n",
       "861    chloroquine and hydroxychloroquine in the trea...   \n",
       "12389  this issue has rapidly reviewed and published ...   \n",
       "16319  a narrative letter by chinese authors reported...   \n",
       "13044  breakthrough: chloroquine phosphate has shown ...   \n",
       "6363   chloroquine and hydroxychloroquine for the tre...   \n",
       "8197   although the binding of sars-cov to sialic aci...   \n",
       "10686  despite its small sample size our survey shows...   \n",
       "5970   chloroquine phosphate and hydroxychloroquine w...   \n",
       "16450  based on in vitro evidence and still unpublish...   \n",
       "3481   27 experts in china have suggested the use of ...   \n",
       "14223  conclusion: current pharmacovigilance study re...   \n",
       "4267   evaluating the potentially favorable benefit-r...   \n",
       "1254   currently, there is no vaccine or specific dru...   \n",
       "6756   randomised trials evaluating chloroquine and h...   \n",
       "13961  no evidence of clinical efficacy of hydroxychl...   \n",
       "9900   no evidence of rapid antiviral clearance or cl...   \n",
       "\n",
       "                                                  sent_2     prediction  \\\n",
       "730    no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "9507   no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "337    no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "12651  no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "4136   no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "13175  no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "15402  no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "1385   no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "11734  no evidence of rapid antiviral clearance or cl...  contradiction   \n",
       "2040   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "11603  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "14354  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "2564   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "4398   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "1123   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "10555  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "9376   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "3219   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "2957   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "9638   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "16057  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "9245   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "599    no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "10817  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "75     no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "3350   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "5184   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "10424  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "6494   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "2695   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "...                                                  ...            ...   \n",
       "4529   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "10948  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "7542   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "10031  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "13699  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "15009  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "7018   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "9769   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "4791   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "10162  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "6625   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "1516   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "15533  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "6101   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "861    no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "12389  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "16319  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "13044  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "6363   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "8197   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "10686  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "5970   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "16450  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "3481   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "14223  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "4267   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "1254   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "6756   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "13961  no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "9900   no evidence of rapid antiviral clearance or cl...     entailment   \n",
       "\n",
       "      contradiction entailment  neutral  \n",
       "730         0.79144    0.20855  0.00001  \n",
       "9507        0.75227    0.24766  0.00006  \n",
       "337         0.68502    0.31487  0.00011  \n",
       "12651       0.66036    0.33917  0.00047  \n",
       "4136        0.64726    0.35263  0.00010  \n",
       "13175       0.62030    0.37968  0.00002  \n",
       "15402       0.58796    0.40958  0.00246  \n",
       "1385        0.57954    0.41988  0.00058  \n",
       "11734       0.57592    0.42383  0.00024  \n",
       "2040        0.49828    0.50165  0.00007  \n",
       "11603       0.48273    0.51630  0.00097  \n",
       "14354       0.43519    0.56382  0.00099  \n",
       "2564        0.42379    0.57617  0.00004  \n",
       "4398        0.42174    0.57822  0.00004  \n",
       "1123        0.41992    0.57986  0.00023  \n",
       "10555       0.36987    0.63009  0.00004  \n",
       "9376        0.36649    0.63347  0.00004  \n",
       "3219        0.35376    0.64554  0.00070  \n",
       "2957        0.34967    0.64980  0.00053  \n",
       "9638        0.33950    0.66048  0.00002  \n",
       "16057       0.33198    0.66795  0.00007  \n",
       "9245        0.31237    0.68636  0.00127  \n",
       "599         0.30684    0.69248  0.00067  \n",
       "10817       0.30450    0.69493  0.00057  \n",
       "75          0.30160    0.69765  0.00075  \n",
       "3350        0.29411    0.70542  0.00047  \n",
       "5184        0.29304    0.70680  0.00016  \n",
       "10424       0.27600    0.72319  0.00082  \n",
       "6494        0.27590    0.72374  0.00035  \n",
       "2695        0.27434    0.72546  0.00020  \n",
       "...             ...        ...      ...  \n",
       "4529        0.04441    0.95551  0.00008  \n",
       "10948       0.04295    0.95680  0.00025  \n",
       "7542        0.04283    0.95714  0.00003  \n",
       "10031       0.04115    0.95883  0.00002  \n",
       "13699       0.04004    0.95993  0.00003  \n",
       "15009       0.03267    0.96528  0.00205  \n",
       "7018        0.03067    0.96929  0.00004  \n",
       "9769        0.02819    0.97179  0.00002  \n",
       "4791        0.01997    0.97959  0.00043  \n",
       "10162       0.01717    0.98203  0.00080  \n",
       "6625        0.01656    0.98333  0.00011  \n",
       "1516        0.01537    0.98452  0.00010  \n",
       "15533       0.01530    0.98446  0.00024  \n",
       "6101        0.01483    0.98503  0.00014  \n",
       "861         0.01152    0.98801  0.00047  \n",
       "12389       0.01006    0.98992  0.00002  \n",
       "16319       0.00928    0.99058  0.00014  \n",
       "13044       0.00723    0.99272  0.00005  \n",
       "6363        0.00718    0.99257  0.00025  \n",
       "8197        0.00619    0.99302  0.00079  \n",
       "10686       0.00440    0.99557  0.00003  \n",
       "5970        0.00359    0.99623  0.00019  \n",
       "16450       0.00337    0.99663  0.00000  \n",
       "3481        0.00232    0.99752  0.00016  \n",
       "14223       0.00200    0.99795  0.00004  \n",
       "4267        0.00106    0.99886  0.00009  \n",
       "1254        0.00070    0.99927  0.00003  \n",
       "6756        0.00061    0.99932  0.00008  \n",
       "13961       0.00020    0.99980  0.00001  \n",
       "9900        0.00017    0.99983  0.00000  \n",
       "\n",
       "[131 rows x 6 columns]"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_df.sort_values(by='contradiction', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "chloro_results_df.to_csv('../output/chloroquine_sentences_nli_200505.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "entailment       13405\n",
       "neutral           2378\n",
       "contradiction     1378\n",
       "Name: prediction, dtype: int64"
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chloro_results_df.prediction.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv('../../../../resources/mednli/input/claims_flag_sentence_cord_uid.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'str'>\n",
      "the recombinant protein reported here, together with the detailed structural information, might also be useful to others developing sars-cov-2 diagnostics and/or therapeutics.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results suggest that sars-cov infection may target the cell types that are important for the protection of airway mucosa and their damage may lead to deterioration of epithelial cell function, finally leading to a more severe lung disease with accumulation of alveolar exudate and inflammatory cells and lung edema, the signs of pneumonia recently described in the lung specimens of two patients with covid-19 infection (60) .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results show putative binding sites for several transcription factors which have a strong correlation of expression with ace2 in colon, kidney, and ileum.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "gene ontology annotation results for the processes associated with genes strongly coexpressed (≥0.5) with ace2 across all tissues in gtex dataset.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, our simulations suggest that even in the more optimistic scenario, where all the age groups reduce their contact rates over 85%, the epidemic is set to rebound once the social distancing interventions are lifted.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that social distancing interventions can \"buy us\" several weeks that could prove to be essential to strengthen our health systems and restock medical supplies, but will fail to mitigate the current pandemic.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this is in agreement with other modeling results which suggested that very long periods of social distancing would be needed to control transmission [20] .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that the infectious period is a key parameter that has an extraordinary influence in the modeled speed of an epidemic and hence in the effectiveness of the interventions considered.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "taken together, our results suggest that more aggressive approaches need to be taken to mitigate the transmission of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "furthermore, this study strongly supports the repurposing of heparin and its derivatives as antiviral agents, providing a rapid countermeasure against the current sars-cov-2 outbreak.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "14- 16 we thus speculate that th2 immune response in asthmatic patients may counter the 367 inflammation process induced by sars-cov-2 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this idea is based on observations that the angiotensin-converting enzyme 2 (ace2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " this study confirms that fever, cough, and breathing difficulties are the major symptoms of covid-19 infection among pregnant women, which are similar to general infected patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings may help healthcare providers to take proper initiatives.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "despite these limitations, this study has enough merits, which will make healthcare providers informed about the symptoms, treatments, and possible outcomes in pregnant women detected with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this would be the first successful use of cq in humans for treating acute viral disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is also recommended to further research on the role of cq for covid-19 prevention.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it has also been urged in an article that the above cq regimens be investigated in parallel with the mass deployment of this drug, without unnecessary regulatory delays, in an attempt to contain the global pandemic as the benefits of cq far outweigh the risks or costs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "more data from ongoing and future trials will add more insight into the role of chloroquine and hydroxychloroquine in covid-19 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "given the current availability of literature, caution should be exercised until further evidence emerges surrounding the use of nsaids\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " covid-19 and treatment with nsaids and corticosteroids: should we be limiting their use in the clinical setting?\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results show that the 17 organosulfur compounds, accounting for 99.4% contents of the garlic essential oil, have strong interactions with the amino acids of the ace2 protein and the main protease pdb6lu7 of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "interestingly, docking results indicate the synergistic interactions of the 17 substances, which exhibit good inhibition of the ace2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the fact that tissue injury and death may be related to a pro-inflammatory process resulting from the viral infection suggests that the use of il-1β blockers or il-18 blockers may have some benefit in covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results also showed that the high expression of ace2 increased the expression of genes involved in viral replication, which may enhance the ability of the virus to enter the host cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our calculations support the hypothesis that the transcriptome of epithelial cells is altered after infection by sars-cov-2 through increased ace2 expression, which is beneficial to the replication and assembly of virus, and also to the entry of virus into host cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings may help clinicians and researchers gain more insight into the pathogenesis and use this to design therapeutic strategies for covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "note that all results in this study are based on data mining and basic science and translational studies are required to confirm these models.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results show that man-e-l3 can be probed in a less amount on sh slides to present stronger fluorescent intensities, which are consistent with the above binding tendencies.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "since the results showed that the immobilization of 30 mmol·l it shows the similar sensitivity as previous report of the detection of e. coli strains [24] , which needs a bacterial enrichment step prior to detection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results showed that microarray probed with the single mannose structure is not enough for the detection of bacteria with various serovars or subtypes, which contain a high degree of allelic variation in adhesin.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we suggest that a complex carbohydrate microarray containing different glycan conformation may be needed for detection of different bacteria isolates.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[key words] carbohydrate microarray; mannose; fimh; adhesin [clc number] r965 [document code] a [article id]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " remdesivir as a possible therapeutic option for the covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions: this study does not provide evidence to support that ace inhibitor antihypertensive drugs affect lung ace2 and tmprss2 expression or plasma ace2 levels.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in the current covid-19 pandemic, our findings do not support a change in ace inhibitor medication use without clinical justification.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our analyses revealed that the top 10 nine hits might serve as potential anti-sars-cov-2 lead molecules for further optimisation and 11 drug development process to combat covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings need to be interpreted with caution; given vulnerable health systems and high levels of comorbidities in lmics, if an exponential rise of cases followed by deaths were to occur in ensuing weeks, this would alter the epidemiological predictions in this report.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the findings warrant deeper epidemiological scrutiny and prospective evaluation in individually randomized trials.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "importantly the findings in this report illustrate the pivotal role that continuous systematic laboratory surveillance will have in improving our understanding of the pandemic, particularly in lmics.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "such data lead to informed policy making that are beneficial to health and economic outcomes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our data indicate that in patients with severe covid-19 pneumonia, early, lowdose and short-term application of corticosteroid was associated with a faster improvement of clinical symptoms and absorption of lung focus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " baricitinib - a januase kinase inhibitor - not an ideal option for management of covid 19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "48 however, absolute risk in our study should be interpreted cautiously since patients with ra are likely different from those with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "as the world awaits the results of clinical trials for the anti-viral efficacy of hcq in the treatment of sars-cov2 infection, this large scale, international real-world data network study enables us to consider the safety of the most popular drugs under consideration.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "hcq appears to be largely safe in both direct and comparative analysis for short term use, but when used in combination with azm this therapy carries double the risk of cardiovascular death in patients with ra.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "whereas we used the collective experience of a million patients to build our confidence in the evidence around the safety profile, the current evidence around efficacy of hcq+azi in the treatment of covid-19 is quite limited and controversial.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the findings of the survey may help shape future evidence-based opinions on managing patients with is during covid-19 pandemic.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "articles regarding artificial intelligence in this context were found for automatic 1 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200405-sitrep-76-c ovid-19.pdf?sfvrsn=6ecf0977_2 2 https://www.saude.gov.br/noticias/agencia-saude/46623-brasil-inicia-a-distribuicao-de-500-mil-testes-r apidos assessment of chest ct. previous studies correlated the c reactive protein to viral infections, mildly elevated alanine aminotransferase (alt) in acute respiratory distress syndrome (ards\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we suggest that the nutritional status of each infected patient should be evaluated before the administration of general treatments and the current children's rna virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "those results indicate that older adult males with chronic underlying disease might be more susceptibility to covid-19 or mers-cov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "more large-sample, multicentre, high-quality research should be performed to update this study.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "designed mev in present study could be a potential candidate for further vaccine production process against covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, to ensure its safety and immunogenic profile, the proposed mev\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results may provide insight into the immunomodulation mechanisms of hcq treatment in the setting of covid-19 and suggest hcq all rights reserved.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " comparative in vitro transcriptomic analyses of covid-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of sars-cov-2 host response genes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "if imaging shows the presence of typical manifestations of 2019-ncov, even if the naat result for the detection of sars-cov-2 is unavailable or negative, it is still necessary to take isolation measures to avoid the spread of the epidemic.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this obvious discrepancy suggests that mechanisms other than ace2 expression level also play important roles in establishing efficient and successful infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "based on our above analysis by pscrna expression profiling, we propose that three more factors, in addition to the mrna level, should be taken into account in predicting the vulnerability of a specified target tissue/organ.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "together, we provide a comprehensive view on the potential sars-cov-2 targets by pscrna\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that cr3022 may have the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-ncov infections.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "m396, cr3014) that target the ace2 binding site of sars-cov failed to bind 2019-ncov spike protein, implying that the difference in the rbd of sars-cov and 2019-ncov has a critical impact for the cross-reactivity of neutralizing antibodies, and that it is still necessary to develop novel monoclonal antibodies that could bind specifically to 2019-ncov rbd\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results demonstrate this could be a valuable methodology for rapid prototyping, evaluation, and validation of fit in a non-clinical environment for use in creation of ppe.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this method should be not be used without confirmation in a formal qualitative or quantitative fit test but can be used to preserve those resources until developers are confident that potential new n95 comparable respirators will pass.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we strongly suggest validation of masks and respirators with occupational safety and health administration (osha\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we suggest utilizing gtp as a seed to obtain specific inhibitors against sars-cov-2 rdrp using its high-quality model.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "j o u r n a l p r e -p r o o f acknowledgment: mrs. kauther m shaltoot is appreciated for her kind help and support; without her, this work was not possible.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "dr. wael elshemey is appreciated for guidance and performing the docking calculations on his computational facility.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the low cost of chloroquine and hcq could also be an effective strategy to counter covid-19 (especially in patients with diabetes and other co-morbidities in whom mortality is high) in resource constrained and covid-19 overburdened heath care systems in middle-and low-income counties including india.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results are consistent with several introductions of sars-cov-2 in europe and/or further circulation of the single strain originating in wuhan with concurrent evolution and accumulation of mutations.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "nevertheless, these data may be useful to understand the dynamics of the local transmission of sars-cov-2 in europe.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this raises questions regarding the role of ace2 for infection of human lungs, and highlights the need to further explore the route of transmission during sars-cov-2 infection to understand the biology of the disease and to aid in the development of effective treatments to the viral infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results demonstrate that the impaired fibrinolytic niche in influenza-infected lungs and genetically engineered mice modeling impaired fibrinolytic niche results in a significant decline in the proliferative at2 and differentiated at1 cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results thus demonstrate the novel finding that that the fibrinolytic niche may be critical for realveologenesis.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study demonstrates a new mechanism that the cd44 receptors at the plasma membrane of at2 cells are a key player for at2 cell-mediated re-alveolarization.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in addition to the reduction in at2 cells in injured mouse and human lungs associated with aberrant fibrinolytic niche, both plau -/and serpine1 tg at2 cells cannot develop organoids equal to those of wt mice in vitro, mostly likely due to the author/funder.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "together with abnormal enac activity in plau -/and serpine1 tg at2 cells, we conclude that the enac signal may be an essential regulator for the fate of at2 cells in normal and injured lungs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, our study uncovers a novel role of the fibrinolytic niche in alveolarization via the upa/a6/cd44 and the upa/enac signaling pathways.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this study provides new evidence for the possible prognostic relevance of the fibrinolytic niche for ards patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "targeting the abnormality of the fibrinolytic niche could be a promising pharmaceutic strategy to accelerate reparative processes of injured alveolar epithelium in clinical disorders such as ards.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this may suggest that the s gene was widely subject to darwinian selection in different coronavirus strains, indicating that it may be crucial for the successful survival of coronaviruses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it should be noted that the 35 evolutionary convergent sites of spike protein were apparently underestimated, since those amino acid sites with alignment gaps were not considered by the approach used.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that the spike protein may have been subjected to a successive evolutionary convergence among ancestral coronavirus strains leading to sars-related cov, covid-19related cov and covzc45 and covzxc21.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our molecular phyloecological study demonstrates that spike protein shows significant darwinian selection along two ancestral branches related to sars-cov and 2019-ncov, suggesting their adaptive evolution to recognizing their own cell receptors.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the measures of restrained advocacy for potentially beneficial effects of hcq and advice against self-medication can help prevent adverse events related to this drug.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the comparative analysis of imaging features, clinical indexes and reexamination are helpful for the differential diagnosis of covid-19 and suspected covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results can contribute to guide the design of new functional and high specific mabs providing a cost-and-time-effective computational framework towards the development of better diagnostic strategies and an effective treatment and/or vaccine for covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " our analyses suggested that convalescent plasma may not have a clinically relevant impact in reducing the rate of mortality in patients with influenza.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " the efficacy of convalescent plasma for the treatment of severe influenza\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " our results indicated convalescent plasma might be a potential therapy for critically ill patients infected with sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the safety and efficacy of convalescent plasma transfusion in sars-cov-2-infected patients should be studied within the context of a well-designed clinical trial.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the present systematic review should provide reassurance to busy clinicians and persons with epilepsy that chloroquine, if prescribed to treat covid-19, lacks any substantial evidence to suggest that the medication increases the risk of seizure.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we may computationally predict a new virus–host interactome for 2019-ncov/sars-cov-2 using sequence-based and structure-based approaches77.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, this study offers a powerful, integrative network-based systems pharmacology methodology for rapid identification of repurposable drugs and drug combinations for the potential treatment of 2019-ncov/sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our approach can minimize the translational gap between preclinical testing results and clinical outcomes, which is a significant problem in the rapid development of efficient treatment strategies for the emerging 2019-ncov/sars-cov-2 outbreak.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "from a translational perspective, if broadly applied, the network tools developed here could help develop effective treatment strategies for other emerging viral infections and other human complex diseases as well.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in fact, one can argue that the alleged tocilizumab efficacy both for treating covid-19 and iraes might suggest a potentially increased danger from sars-cov-2 infection for ici-treated patients, maybe hypothesizing a synergy in the promotion of the viral morbidity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "thus, hoping for positive results from tocilizumab randomized clinical trial on covid-19 patients, we could only argue about the evident diversity of this viral infection from previous sars outbreaks and even more from influenza epidemics, probably both in terms of clinical features and of pathogenetic implications.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study has several strengths: first, we provide a practical quantitive prediction tool based on only 7 features which were relatively inexpensive and easy to be obtained directly from the routine blood tests.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, our data suggest that our nomogram could early identify the severe covid-19 patients, and rdw was vaulable for prediction of severe diseases.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our nomogram is especially valuable for risk stratification management, which will be helpful for alleviating insufficient medical resources and reducing mortality.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "26 one possible implication of this is that, arbidol combine with lpv/r might benefit to delay of the progression of lung lesions and lower the possibility of respiratory and gastrointestinal transmission for decreasing the viral load of covid-19 and containing a high fecal concentration.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "further randomized, prospective studies are still needed, and the mechanism of its antiviral effect to coronavirus remains unclear.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "such measurements should be included in any future clinical studies exploring the therapeutic benefit of any antiviral intervention for patients with sars-cov-2 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusion: in patients with covid-19, the apparent favorable clinical response with arbidol and lpv/r supports further lpv/r only.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, respiratory indices should be one of the top priorities in the efficacy evaluation.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the present study suggests that elevated c-reactive protein, and decreased albumin are factors associated with poor prognosis of covid-19 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "taken together, these findings reveal a proteomic vulnerability of sars-cov-2 to methylglyoxal modification and provide a rationale for repurposing doxorubicin and paclitaxel for covid-19 treatment.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "17 this indicate that eosinophils could assist in the diagnosis and severity assessment of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is hoped that our study may provide the basis for the epidemiology related measures of patients in covid-19 import area as well as for clinicians to make medical decisions.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, the treatment experience in our study should be carefully thought when treating patients in different places and circumstances, and further researches are needed to verify the the safety and efficacy.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings could be further validated in an appropriate animal model, and hopefully developed through subsequent clinical trials in order to provide additional therapeutic options for patients with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " covid-19 and the raas—a potential role for angiotensin ii?\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "all these findings indicated that the balance of gut microbiota can be disrupted in case of coronavirus infection due to the immune disorder.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "based on our findings, we suggested that the early interventions of host immune system and gut microbiota are necessary for covid-2019 patients with refractory hypoxia.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "hypoxemia severity was closely related with host immune cell levels, and the vicious circle between immune disorder and gut microbiota imbalance may be a high risk of fatal pneumonia.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "moreover, treatment with methylprednisolone may be beneficial for patients who develop ards\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " for ethical reasons and because our first results are so significant and evident we decide to share our findings with the medical community, given the urgent need for an effective drug against sars-cov-2 in the current pandemic context.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we therefore recommend that covid-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of covid-19 in the world.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "further works are also warranted to determine if these compounds could be useful as chemoprophylaxis to prevent the transmission of the virus, especially for healthcare workers.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study has some limitations including a small sample size, limited long-term outcome follow-up, and dropout of six patients from the study, however in the current context, we believe that our results should be shared with the scientific community.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in covid-19 patients and its effect is reinforced by azithromycin.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, by respectively analyzing the patients with coinfection of sars-cov-2 and hbv, we found that the patients with pre-existing hbv infection will be much more vulnerable to sars-cov-2 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "during the pandemic of sars-cov-2 infection, hbv patients should be given the specific protection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "given that most infections in zhejiang province were in patients who had no direct contact with the original site of outbreak, our findings provide valuable information in the understanding of the clinical features of covid-19, as the number of people with confirmed disease continues to increase rapidly.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study population might represent most of the clinical characteristics of infected patients since january 2020. further containment proposals should be implemented by the chinese government, such as preventing people from wuhan having contact with those elsewhere, banning gatherings of more than 100 people, conducting daily public-wide educational campaigns on precautionary measures against exposure to sars-cov-2, encouraging people to cancel traditional family gatherings such as during the chinese lunar new year, and extending the chinese lunar new year holiday to prevent large scale spread.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study suggests unique structural features of the spike glycoprotein rbd of 2019-ncov that confers potentially higher affinity binding for its receptor than found with sars-cov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is certainly worthwhile to test these drugs for their ability to block the rbd/ace2 interaction.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that both drugs functioned at the post-entry step.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that nelfinavir, lopinavir, and tipranavir can achieve ec 50 of each drug in human and are effective in the treatment of covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these data indicate that nelfinavir is the best of nine drugs as a potential drug candidate for the treatment of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings reveal that nelfinavir is highly effective in inhibiting sars-cov-2 replication in vitro and has the high c max -ec 50 and c tough -ec 50 ratio.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we suggest that nelfinavir is a potential candidate drug for the treatment of covid-19 and should be assessed in the patients with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that nelfinavir is a potential candidate drug for the treatment of covid-19 and should be assessed in patients with covid-19 all rights reserved.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results indicated that beside the antiviral efficacy, the antibody response might be associated with secondary antibody-mediated organ damage.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "nevertheless, our findings indicate that severe covid-19 was associated with a more robust igg response that can be developed as an acquired immunity-related marker to predictive disease severity, along with other innate immunity-relate makers such as nlr.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "further study on the immunopathogenesis of sars-cov-2 infection is warranted.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "further research should be directed toward the study of sars-cov-2 in suitable animal models for analyzing replication, transmission, and pathogenesis.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " efficacies of lopinavir/ritonavir and abidol in the treatment of novel coronavirus pneumonia\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " our results showed that ace2 and tmprss2 were expressed in the human kidney, indicating that the kidney is a potential target organ of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings may suggest that antibodies or biological inhibitors targeting virus proteins such as spike protein, the ace2 receptor, or protease tmprss2 could potentially be part of therapeutic strategies.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "early interventions, including continuous renal replacement therapies, should be applied as early as possible to preserve kidney function in patients who show signs of kidney failure such as increased concentrations of urine protein, blood urea nitrogen, or plasma creatinine.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "all these results provide insights that cd147 acts as a functional entry receptor for sars-cov-2, and serves as a therapeutic target for inhibiting virus infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "4.22 these results suggest that the excess immune cells migrating into lung tissue may cause uncontrolled immune response, leading to the inflammation storm, and aggravated disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "blocking the cytokine axis il6 appears to us a promising therapy to be studied urgently in patients developing severe acute respiratory syndrome related to coronavirus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "to best of our knowledge, this is the first study to identify certain peptides in envelope (e\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study revealed the phenomenon and possible cause of mild pancreatic injury in patients with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this suggests that pancreatitis after sars-cov-2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "27 in our study, despite no death in pregnant women and neonates, our finding suggested that more attention should be paid to the pregnant women especially to those who had a history of exposure to the all rights reserved.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings plainly indicated that it was not enough to screen pregnant women for covid-19 based solely on clinical symptoms.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings suggested that sars-cov-2 could not penetrate the placental and blood-milk barriers.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings will be crucial to inform prophylactic and therapeutic strategies for pregnant women with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions and relevance: in this single-center case series of 138 hospitalized patients with confirmed ncip in wuhan, china, presumed hospital-related transmission of 2019-ncov was suspected in 41% of patients, 26% of patients received icu\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "indeed, our results demonstrate that the potency of atv and atv/rtv potency against sars-cov-2 in a549 cells is likely to be consistent with their bioavailability in the lungs in experimental models 18, 34 .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results reveled that cellular mortality and cytokine storm-associated mediators were reduced after treatment with the repurposed antiretroviral drugs used in this study.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, our study highlights a new option among clinically approved drugs that should be considered in ongoing clinical trials for an effective treatment for covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results show that atv could dock in the active site of sars-cov-2 mpro, with greater strength than lpv.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we confirmed that atv inhibits sars-cov-2 replication, alone or in combination with ritonavir (rtv\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " atazanavir inhibits sars-cov-2 replication and pro-inflammatory cytokine production\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, our results suggested that the occurrence of hepatic injury was related to the deterioration of the disease with a dynamic process.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "early detection and timely treatment are helpful for the recovery of liver function.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " remdesivir, lopinavir, emetine, and homoharringtonine inhibit sars-cov-2 replication in vitro\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, spinal anaesthesia appears to be safe in mildly symptomatic covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study suggests that using level 3 ppe is likely to reduce the risk to anaesthetic staff of acquiring covid-19 even from patients with mild symptoms.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "considering the significance of this ongoing global public health emergency, our report contributes valuable data to inform the perioperative community.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " favorable changes of ct findings in a patient with covid-19 pneumonia after treatment with tocilizumab\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this study provides valuable 45 information regarding humoral immune responses against sars-cov and the 2019-ncov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " our report of the first confirmed case of 2019-ncov in the united states illustrates several aspects of this emerging outbreak that are not yet fully understood, including transmission dynamics and the full spectrum of clinical illness.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this case report highlights the importance of clinicians eliciting a recent history of travel or exposure to sick contacts in any patient presenting for medical care with acute illness symptoms, in order to ensure appropriate identification and prompt isolation of patients who may be at risk for 2019-ncov infection and to help reduce further transmission.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "finally, this report highlights the need to determine the full spectrum and natural history of clinical disease, pathogenesis, and duration of viral shedding associated with 2019-ncov infection to inform clinical management and public health decision making.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "a similar effect can be expected against the sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we hope that open access to this reagent will expedite development of medical countermeasures.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our analyses revealed species and tissues susceptible to sars-cov-2 infection, thus yielding novel insights in tracing the origin and transmission of the virus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in this open-label nonrandomized control study, fpv showed significantly better treatment effects on covid-19 in terms of disease progression and viral clearance; if causal, these results should be important information for establishing standard treatment guidelines to combat the sars-cov-2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the possibility that overall lower sensitivity of sars-cov-2 igg elisas may be a more universal occurrence rather than manufacturer dependent warrants further investigation.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our data suggest that the viral shedding from the urt may reach its peak during the first 3-5 days after illness onset.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings suggest that the transmissions of sars-cov-2 may occur easily and begin from the prodromal phase of illness, just like common cold or influenza viruses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "considering that the median time from symptom onset to isolation of the patients was 3 days, and that high titers of virus shedding began from day 1 of illness with the peak around day 3–5 of illness, early detection and isolation strategy may be relatively less effective in containing the virus in covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results regarding outcomes in this study should be interpreted cautiously.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study suggests that (1) the prodromal symptoms of sars-cov-2 infection were mild, (2) radiological pneumonia was very common, and developed from the early days of illness, (3) pneumonia may progress at day 7 of illness, (4) high titers of the virus shed from the urt during the prodromal phase (5), and the median time from symptom onset to defervescence was 10 days and to off-isolation 18.5 days.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of covid-19 patients with hypertension\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "nevertheless, our findings suggest that, even in paucisymptomatic patients, consecutive multiple-site biological samples may be required in settings with limited community transmission for discontinuation of infection control and transmission-based isolation precautions.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we should therefore act cautiously before initiating prospective interventional studies on the use of hcq\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "https://doi.org/10.1101/2020.03.18.997585 doi: biorxiv preprint available fda approved drugs, they can be evaluated quickly in laboratory and clinical settings for covid-19 treatment.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we demonstrated the ability of these three viral polymerase inhibitors, 3'-fluoro-3'-deoxythymidine triphosphate, 3'-azido-3'deoxythymidine triphosphate and tenofovir diphosphate (the active triphosphate forms of alovudine, azt and taf, respectively) to be incorporated by sars-cov-2 rdrp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that lymphocytes may be a direct target of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that lymphocyte reduction at the early stage may be a potential indicator of multiple organ injures among covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results indicate that lymphocyte reduction elevates the severity .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the present study provides evidence that lymphocyte reduction on admission may be a potential negative prognostic indicator for covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that lymphocytes may be a direct target of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we provide evidence that lymphocyte reduction at early stage may be a potential negative prognostic indicator for covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, surveillance of lymphocyte count is helpful for the early screening, diagnosis and treatment of critical ill covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "results of the clinical trials currently underway in the u.s. and china will provide crucial information about whether remdesivir represents a viable treatment option for covid-19 [20,49].\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "if the trial findings are ultimately positive, it will be imperative to ensure that the drug is produced on a commercial scale capable of meeting the demand generated by both the current pandemic and future outbreaks.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "such a change in production may also allow for the added benefit of the drug becoming more available for agricultural and veterinary use for relevant indications.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "2.appropriate dose of methylprednisolone can effectively avoid invasive mechanical ventilation and reduce case fatality rate in critical covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, the mortality was relatively lower in critically ill patients with sars-cov-2 infection in guangdong province.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these data provide some general understandings and experience for the critical patients with sars-cov-2 outside of wuhan.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "two randomised clinical trials of parenteral remdesivir therapy in the treatment of covid- 19 in china may open the window for effective antiviral therapy for such an epidemic infectious disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " arguments in favour of remdesivir for treating sars-cov-2 infections\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions the epidemiological characteristics of cases with covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these data suggested that isolation for at least 21 days after the onset of symptom or first positive pcr test is warranted in both patients without or with improving symptoms.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in patients with covid-19, isolation for a minimum of 21 days after onset of illness may be warranted, while the use of antiviral drugs does not enhance viral rna clearance.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, we highly recommend that all people with an exposure history be strictly quarantined, and for immunocompromised people with long-term use of glucocorticoids, this time should not be limited to 14 days.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "and if it does, we hope that this simple qtc surveillance strategy, enabled by innovation and the fda's emergency approval, will help prevent altogether or at least substantially reduce the number of druginduced ventricular arrhythmias and sudden cardiac deaths, particularly if there is widespread adoption and utilization of these medications for covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "with the possibility that a considerable q6', 'cite_spans': [], 'ref_spans': [], 'section': 'abstract'}]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "finally, although baricitinib has the potential to affect sars-cov2 penetration into pulmonary epithelial cells, major concerns remain about the inhibition of ifns activity which could be detrimental in the course of viral infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study proposed that convalescent plasma should be used in advance especially for female patient with low igg antibody for a long time to prevent the disease from progressing to severe and critical status, if the convalescent plasma is available.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "and monitoring igg antibody maybe a potential method to assess covid-19 progression.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "2, 4 these findings suggested that lower respiratory tract seems to be an important location for the replication of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the finding that the proteins encoded by the de novo frames differ significantly from those encoded by the ancestral frames supports the view that overprinting is a valuable source of genetic novelties.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the further impact of covid-19 on patients' kidney function, especially the incidence of chronic kidney disease in these patients should be the focus of future research.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "clinicians should increase their awareness of kidney impairment in hospitalized covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "continued vigilance is required to identify new cases.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " use of siltuximab in patients with covid-19 pneumonia requiring ventilatory support\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the authors appraise the study generating this interest and highlight the potential consequences of rapid dissemination of overinterpreted data, particularly for people with conditions for which hydroxychloroquine has demonstrated benefits in preventing organ damage and life-threatening disease flares.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "lymphocyte count, total serum protein, and hdl-c may be potentially useful for the evaluation of covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "5, 26 in summary, these results demonstrate that the nucleotide analogues tfv-dp and ec-tp are permanent terminators for the sars-cov-2 rdrp catalyzed reaction.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "their prodrug versions (taf or tdf and emtricitabine or emtricitabine-5'-o-phosphoramidate that can be readily synthesized using the protide prodrug approach 27 ) can be used as lead compounds for covid-19 therapeutics development.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "more importantly, since these molecules are contained in the fda-approved combination drugs truvada and discovy, our results provide a molecular basis to further evaluate them in sars-cov-2 virus inhibition and animal models to test their efficacy for the development of potential covid-19 medications.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these current and future studies may also provide potential options for preventing covid-19 infection in a manner similar to prep for hiv prevention.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results provide a molecular basis to evaluate the potential of descovy and truvada as prep\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that this new hcov has evolved with improved binding affinity between hr1 and hr2 domains, which may accelerate the viral membrane fusion process and enhance viral infectivity or transmissibility.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "ek1c4 showed prolonged and significant prophylactic effect against hcov-oc43 infection in mouse model, suggesting that ek1c4 may also be used as an inhibitor against sars-cov-2 infection in vivo.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, ek1c4 shows exceptional promise to be developed as the first pan-cov fusion inhibitor-based antiviral therapeutic or prophylactic for treatment or prevention of infection by the currently circulating sars-cov-2 and mers-cov and the future reemerging sars-cov and emerging sarsr-covs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the trial of gautret and colleagues, with consideration of the effect sizes, and p-values from multiple models, does not provide sufficient evidence to support wide-scale rollout of hcq monotherapy for the treatment of covid-19; larger randomized studies should be considered.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these data also suggest further randomized-controlled studies of hcq-az combination therapy should be undertaken.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our docking results show that remdesivir-tp binds to sars-cov-2 rdrp, with a score of -112.8, and the docking results are consistent with its original anti-viral mechanism, so we think remdesivir may be good in treating sars-cov-2 pneumonia.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we may computationally predict a new virus-host interactome for hcovs using sequence-based and structure-based approaches [70] .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "thus, combination of the existing anti-virus drugs (such as remdesivir [76] ) with the networkpredicted repurposable drugs (figure 5 ) or drug combinations (figure 6 ) may improve coverage of current network-based methodologies by utilizing multi-layer network framework.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, this study offers a powerful, integrated network-based systems pharmacology methodology for rapid identification of repurposable drugs and drug combinations for the potential treatment of hcov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our approach can minimize the translational gap between preclinical testing results and clinical outcomes, which is a significant problem in the rapid development of efficient treatment strategies for the emerging 2019-ncov outbreak.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the structures we describe here could potentially be utilised in drug screening and targeting experiments to disrupt a dimer interface known to be important for coronavirus replication.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "furthermore, it will be guided by the prisma statement [25] and a measurement tool to assess systematic reviews (measurement tool to assess systematic reviews\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in patients with sars-cov-2 infection\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions the coagulation function in patients with sars-cov-2 is significantly deranged compared with healthy people, but monitoring d-dimer and fdp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we noted low sensitivity of upper respiratory specimens for severe acute respiratory syndrome coronavirus 2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "14 our study indicates that gender is not the core factor accounting for death based on the multivariate cox regression analysis.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results indicated that the high rates of emergency and general anaesthesia use were likely due to the high risk for parturients and newborn.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results provide information that can be essential when the use of chloroquine is considered for the treatment of patients with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusion: current pharmacovigilance study results did not suggest any potential link between the use of chloroquine and an increased risk of suicide, psychosis, confusion, and agitation, which would be informative during the emergency use of chloroquine for the treatment of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results underline the relevance of this model for the preclinical evaluation of antiviral candidates.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "foremost, we provide evidence on the antiviral 40 efficacy of remdesivir and the therapeutic potential of the remdesivir-diltiazem combination as a rapidly available option to respond to the current unmet medical need imposed by covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      ": biorxiv preprint 65 reported the advantage of using more physiological models such as in-house or commercially available reconstituted human airway epithelia (hae\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results seem to indicate that this modeling approach is sufficient at present for germany: while we introduced fairly broad priors on the spreading rates we obtained a fairly narrow posterior distribution for the changed spreading rates (fig.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "4 b) , indicating that the assumption of discrete steps in the spreading rates is viable.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "likewise, our behavior now determines whether or not we will continue to see exponential growth of case numbers, or whether we achieve a transition to exponential decay by reducing our contact and consequently the spreading rate sufficiently.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "overall, we suggest that the list of antiviral drugs identified by the mt-dti model should be considered, when establishing effective treatment strategies for 2019-ncov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in this context, both in vitro and in vivo studies have revealed that metronidazole could decrease the levels of several cytokines, which are known to increase during the covid-19 infection, including interleukin (il)8, il6, il1b, tumor necrosis factor (tnf)α, il12, il1α, and interferon (ifn)γ, as well as the levels of c-reactive protein (crp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "sofosbuvir, ribavirin, and remdisivir can be used against the new strain of coronavirus that emerged with promising results.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "gtp derivatives may be used as specific inhibitors against covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, our model provides a broad platform for assessment of all major types of therapies.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results demonstrate the need to differentiate whether duration of viral shedding or viral area under the curve is the more relevant surrogate of severity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "if viral area under the curve is most predictive of poor outcomes, then all forms of antiviral therapy outside of potent post exposure prophylaxis are unlikely to provide clinical benefit.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this result implies that viral clearance slope in clinical trials can be used in concert with our model to directly estimate the in vivo intracellular ec50 value of remdesivir in each treated patient.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the model can then be used to project the effect of increasing or decreasing doses in subsequent trials.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we also identify that clinically meaningful drug resistance is less likely to emerge with a highly potent agent that is dosed after peak viral load.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results support an early test and treat approach for covid-19, but also demonstrate the need to identify early viral shedding kinetic features that are the most predictive surrogates of clinical severity and transmission risk.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " new insights on the antiviral effects of chloroquine against coronavirus: what to expect for covid-19?\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our analysis of the published data on the status of vit d and crplevels (in the us) and laboratory data (in the us) and laboratory data (crplevels (in the us) and laboratory data) reported from 792 patients in china suggests that a proper supplementation of vit d\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results show that among the variables considered in the present study, the diabetes percentage of the total population and the population age 65 and higher had significant correlation with the total nd recorded in each country as of 06 april 2020. while the effect of the latter factor has been known, the fact that our statistical model correctly highlights its correlation indicates its internal consistency.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "instead, we hope that the findings presented here will encourage a larger cohort study or potentially some randomly controlled trials.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions the present study shows that abnormal coagulation results, especially markedly elevated d-dimer and fdp are common in deaths with ncp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " no evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe covid-19 infection\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "interpretation although all paediatric patients in our cohort had mild or moderate type of covid-19, the large proportion of asymptomatic children indicates the difficulty in identifying paediatric patients who do not have clear epidemiological information, leading to a dangerous situation in community-acquired infections.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the ppe with positive pressure protective hood should be needed to perform bronchoscope-guided endotracheal intubation in patients with covid-19, it could strengthen to protect healthcare workers from virus exposure.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we confirmed this in this study, and further showed that blocking pikfyve and tpc2 also strongly inhibited entry mediated by sars-cov-2 s protein, indicating that pi(3,5)p2 pathway might be considered as potential general drug target for cov infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, we demonstrated that sars-cov-2 s protein entry on 293/hace2 cells is mainly mediated through endocytosis, and that pikfyve, tpc2, and cathepsin l are critical for virus entry.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we further found that sars-cov-2 s protein could trigger syncytia in 293/hace2 cells independent of exogenous protease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings provide potential targets for development of drugs and vaccines against this newly emerging lineage b beta-cov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the result showed that cr3022 neutralizing antibody from human may 39 have higher binding affinity with sars-cov-2 s protein than sars-cov s protein.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we also found that 40 f26g19 and d12 mouse antibodies could bind to sars-cov s\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " covid-19 in a ms patient treated with ocrelizumab: does immunosuppression have a protective role?\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "27, 28 taken together, these results demonstrate that sars-cov-2 directly infects lns and spleens to cause severe tissue damage.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the 40 work reported herein thus demonstrates that ly6e is a critical antiviral immune effector that 41 controls cov infection and pathogenesis via a distinct mechanism.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our data clearly demonstrate that these two enzymes display very similar substrate preferences.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "information provided here can be used for the design of inhibitors and activity-based probes against the sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results of our work provide a structural framework for the design of inhibitors as antiviral agents or diagnostic tests.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings suggest that an oxygenation strategy emphasising optimisation of oxygenation, intubation based on clinical criteria of hyperventilation and avoiding ventilator-induced lung injury associated with non-invasive mechanical ventilation would be life-saving in a significant proportion of patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "structural modeling further demonstrates that the binding site can only be 29 accessed when at least two rbds on the trimeric s overall, this study provides structural and molecular insight into the antigenicity of 31 sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "one sentence summary structural study of a cross-reactive sars antibody reveals a conserved epitope on the 35 sars-cov-2 receptor-binding domain.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, we have provided evidence of a beneficial effect of co-administration of hydroxychloroquine with azithromycin in the treatment of covid-19 and its potential effectiveness in the early reduction of contagiousness.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "given the urgent therapeutic need to manage this disease with effective and safe drugs, and the negligible cost of both hydroxychloroquine and azithromycin, we believe that there is an urgent need to evaluate this strategy further, both to treat and cure patients at an early stage before irreversible severe respiratory complications take hold, and to decrease duration of carriage and avoid the spread of the disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " patients of covid-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of covid-19 progression\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results suggested that renal injury was common in covid-19, which may contribute to multiorgan failure and death eventually.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results suggest that the kidney may be one of the primary targets of attack for the 2019-ncov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we are aware that there are similar modelling, screening and repurposing exercises targeting 3cl\n",
      "pro reported or announced\n",
      "20,\n",
      "27–\n",
      "33. our methods did not overlap, and we share no common results with these studies.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the drugs epclusa (velpatasvir/sofosbuvir) and harvoni (ledipasvir/sofosbuvir) could be very effective owing to their dual inhibitory actions on two viral enzymes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings suggest that it is necessary to detect the indicator of the inflammatory and immune status, which could help doctors to assess the clinical progress, be on alert for severe and critical cases, and provide anti-autoimmune or blood-purifying therapy in time, once cytokine storm occurs [2, 19] .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "finally, it is of crucial importance to assure early isolation combined with best possible psychological support for the young patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results, consistent with the previous findings found in the patients with severe illness, suggest perturbation of immune system contribute the pathogenesis of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "considering the pandemic potential and moderate threaten of covid-19 for population with multiple underlying diseases, further studies are required to focus on pathology and pathophysiology of tissue injury caused by sars-cov-2 infection, especially on the activation process of immune response and cytokines storm.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in this study, we evidence that the anti-sars-cov2 activity of a clinically achievable hydroxychloroquine concentration is maximized only when administered before and after the infection of vero e6 cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this strongly suggests that only a combined prophylactic and therapeutic use of hydroxychloroquine may be effective in limiting viral replication in patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "1101 /2020 can provide real-time guidance for preventing and controlling the epidemic, assessing development trends and the effects of intervention measures [8] .covid-19's \"war epidemic\" and \"epidemic prevention\" strategies are closely related to the important measure of improving the transparency of clinical trials, including sharing of the subject's original data and standardizing trial design, registration, and implementation [9].\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results imply that different interventions have an impact on the design of clinical trials.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, the innovation of this article is to summarize and analyze the registration of chictr's covid-19 clinical research in a timely manner, reflecting the research status and development trend of clinical trials in this field, which is \"time-effective\".\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these data suggest that, at least for rbd-based vaccines, ade is likely to be less of a concern than with vaccines against flaviviruses such as zikv or dengue viruses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "https://doi.org/10.1101/2020.04.10.036418 doi: biorxiv preprint in short, our data suggest that an rbd vaccine could protect many individuals from sars-cov-2 and that it is unlikely to promote infection through conventional ade mechanisms.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "given the exposure of this key neutralizing epitope, the ease with which this compact domain can be produced and presented, and its clear immunogenicity, we propose that the rbd be considered as a key component of any sars-cov-2 vaccine strategy.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study indicates that the technical success rate is unlikely to be a barrier to investments in new vaccines and treatments for infectious diseases, unlike cancer drugs, where the financial risk of new r&d projects comes from the reduced chance of bringing a drug-indication pair from phase 1 to market.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "for that reason, our finding that all four mask models tolerate at least 3 cycles of eto decontamination without significant structural or functional deterioration may be useful.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, we would recommend against the use of this approach unless and until there is advanced testing to ensure that all traces of ethylene oxide and its related breakdown products are entirely eliminated with sufficient aeration [12] .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our data suggests that all decontamination methods are effective for at least one decontamination cycle without loss of structural integrity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusion: multiple factors were related to severe 2019 novel coronavirus pneumonia and composite endpoint, and more related studies are needed in the future.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "another was that our results were based on zhejiang province, far away from j o u r n a l p r e -p r o o f wuhan and sars-cov-2 itself may has virulence changes during human-to-human dissemination, including epidemiological features.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results may suggest general susceptibility.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this finding may suggest that that having pneumonia may be associated with severe disease, and patients tended to have more severe clinical features, which was in accordance with lower oxygenation index, an index to evaluate respiratory function and the severity of the disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "combing clinical features and radiograph score can effectively predict severe/critical type.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "21 taken together, these evidences indicate that disease progression may be a result of an over exuberant host response.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the two phase pattern of the disease progression suggests that early control of viral replication and application of host-directed therapy at later stage is essential to improve the prognosis of cvoid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results of this study provide evidence that mmpd may be a viable treatment option for covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " the impdh inhibitor merimepodib suppresses sars-cov-2 replication in vitro\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "given the paucity of strongly evidence-based regimens, the available data suggest that chinese medicine could be considered as an adjunctive therapeutic option in the management of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, the list of organs where genes sharing local over-expression with the ace2 gene are the most expressed is astonishingly similar to that of the organs affected by covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this target, in addition to other promising drug targets such as the main protease, whose structure was recently determined by our group (18) in complex with an inhibitor (19, 20) will support the development of a cocktail of anti-coronavirus treatments that potentially can be used for the discovery of broad-spectrum antivirals.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "hence, our study 31 has also identified anti-sars-cov-2 therapy candidates that can be readily tested in 32 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is a retrospective study in a single center, and the sample is relatively small, and the observation time is short; continued evaluations of this risk-adapted treatment strategy are needed.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "j o u r n a l p r e -p r o o f 3\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, clinical use should either adhere to the monitored emergency use of unregistered interventions (monitored emergency use of unregistered interventions\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, we found that lopinavir–ritonavir treatment did not significantly accelerate clinical improvement, reduce mortality, or diminish throat viral rna detectability in patients with serious covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these early data should inform future studies to assess this and other medication in the treatment of infection with sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "whether combining lopinavir–ritonavir with other antiviral agents, as has been done in sars5,20 and is being studied in mers-cov,15 might enhance antiviral effects and improve clinical outcomes remains to be determined.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " a trial of lopinavir–ritonavir in adults hospitalized with severe covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings suggest that, while specific antiviral drugs are yet to be developed, currently available antiviral agents should be considered when treating patients with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "nevertheless, our data ought to provide helpful preliminary information at this stage of the covid-19 pandemic.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results also suggest that these differences are related to codon usage preferences.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "again, these analyses revealed that genomic composition affects the codon usage pattern in both, mers-cov and sars-cov-2 viruses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this review also describes the geographical and demographic distribution of covid-19-related liver dysfunction, as well as possible underlying mechanisms linking covid-19 to liver dysfunction, in order to facilitate future drug development, prevention, and control measures for covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the data in this article indicate that darunavir/cobicistat suspensions compounded by pharmacists using as active ingredient a commercially available tablet can be stable at least for one week.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " data on the stability of darunavir/cobicistat suspension after tablet manipulation\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this work demonstrates that both our self-designed candidates and old drugs (leflunomide/teriflunomide) with dual actions of antiviral and immuno-repression may have clinical potentials not only to influenza but also to\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings are supported by previous studies, including the findings reported in 2012 by valencia-garcia et al., which confirmed that increased social capital reduced the levels of depression and anxiety [21].\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "further cohort studies with more samples should be performed, and non-subjective methods should be used.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "for example, sleep can be measured objectively by polysomnography, and stress levels can be detected using objective measurements of serum cortisol levels.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our studies here show that cf respiratory epithelial cell normalization is based on a neutralization of the pre-existing pathologically hyperacidified compartments due to the underlying cf disease, resulting in normalization of glycosylation in cf respiratory epithelial cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we postulate here that the acidotropic and neutralization effects of azt, cpx and cq in normal cells would result in vectorially similar ph shifts away from optimal for the function of enzymes within the secretory pathway that would also alter glycosylation.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our studies here show that azt can reduce furin activity that is abundantly present in respiratory epithelial cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we propose that the drugs studied here, cq, azt and cpx, may modulate these aspects of host-pathogen interactions and virus infectious cycle, with immediate compassionate use in the clinic or in controlled clinical trials.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this shows that ph correction in cf is not limited to azt but that other antibiotics with weak base chemical properties may display this property.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we believe this may in part help understand the potentially beneficial effects of cq/hcq and azt in covid-19, and that the present considerations of hcq and azt for clinical trials should be extended to cpx\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "using a master protocol across international sites can speed the implementation of clinical trials and quickly inform treatment options (https://www.who.int/blueprint/priority-diseases/key-action/multicenter-adaptive-rct-of-investigational-therapeutics-for-covid-19.pdf?ua=1).\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this speculation supports the theory that patients on immunosuppressive treatment could be at lower risk of developing complicated sars-cov-2 complications.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our data cannot definitely ascertain what can be the rate of sars-cov-2 infected patients in our cohort of ibd patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings warrant further investigation, to confirm our preliminary findings and allow implementing guidelines on the management of these patients during the sars-cov-2 global pandemic.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, an alternative rapid and robust reverse genetics platform for rna viruses would benefit the research community.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "here we show the full functionality of a yeast-based synthetic genomics platform for the genetic reconstruction of diverse rna viruses, including members of the coronaviridae, flaviviridae and paramyxoviridae families.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "even if we fail to generate good evidence in time to control the current pandemic, the information will highly impact the way we deal with next coronavirus outbreaks in the future.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "ast/alt ratio, urea nitrogen, tbil and ldh on admission may be potential prognostic indicators.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "early hospitalization is of great significance to prevent multiple organ damage and improve the survival of covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the top designed peptide binders exhibited much stronger binding potency to human cells by binding to angiotensin-converting enzyme 2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the increased expression of il-2r and il-6 in serum is expected to predict the severity of the 2019-ncov\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "2) in the face of sudden outbreaks and life-threatening diseases, no one can use a placebo as a control, so we cannot make sense of exogenous phosphorus supplementation.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "interpretation our findings are consistent with person-to-person transmission of this novel coronavirus in hospital and family settings, and the reports of infected travellers in other geographical regions.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, we should improve the understanding of ncp to prevent missed diagnosis and misdiagnosis; in addition, more rapid and accurate ncp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the important unexpected finding of our study is the stable levels of stress, anxiety and depression despite sharp increases in the number of covid-19 cases between the two surveys as well as statistically but not clinically significant reduction in the psychological impact on the general population.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we believe that decisive and rapid measures imposed by the chinese government were instrumental in reducing further spread of the virus 20 but could safeguarded mental health in the general public.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, we did not further compare the differences between covid-19 and specific pathogen infections.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "collectively, we concluded that lym% was the most sensitive and reliable predictor for disease typing and prognosis.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we recommend that lym% be used independently or in combination with other indicators in the management of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we recommend that lym% be used independently or in combination with other indicators in the management of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the data gleaned from the array could provide invaluable information to the scientific community to understand, detect, and treat covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "other antiviral drugs in pipeline may not be very useful as their productions and supplies to the developing countries may require lengthy timeframe whereas mass production of chloroquine and hydroxychloroquine is already in place in malaria endemic developing countries.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these laboratory abnormalities are similar to those previously observed in patients with mers-cov 22 and\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions the ncp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results suggested that severe pneumonia may be accompanying bacterial infection and immune deficiency may be also a risk factor for unfavourable prognosis in patients 13 .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "2019-ncov may be carries a risk factor of impaired liver and kidney function.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "j o u r n a l p r e -p r o o f journal pre-proof\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "clinical presentation and pathology of covid-19 conclusion: the initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "25 in this study, we found d-dimer greater than 1 µg/ml is associated with fatal outcome of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the prolonged viral shedding provides the rationale for testing novel coronavirus antiviral interventions in efforts to improve outcomes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we show that individual hla, haplotype, and full genotype variability likely influence the capacity to respond to sars-cov-2 infection, and we note certain alleles in particular (e.g.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "unless and until the findings we present here are clinically validated, they should not be employed for any clinical purposes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, we do at this juncture recommend integrating hla testing into clinical trials and pairing hla typing with covid-19 testing where feasible to more rapidly develop and deploy predictor(s) of viral severity in the population, and potentially to tailor future vaccination strategies to genotypically at-risk populations.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this approach may have additional implications for the management of a broad array of other viruses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results of this systematic review highlight the clinical, laboratory, and imaging findings that may assist clinicians anywhere in the globe in suspecting the possibility of covid-19 infection in those with recent travel to areas with ongoing transmission or among contacts of confirmed cases.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "to effectively protect populations and healthcare workers in the face of arrival and spreading of this emerging viral pathogen, constant evaluation of available evidence is essential to guide clinical suspicion, diagnosis, management, and mitigation of transmission of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "hypertensive patients who received acei/arb therapy had a lower risk of developing severe pneumonia compared with those on non-acei/arb antihypertensive therapy, which suggested that acei/arb therapy may be protective from severe pulmonary injury for hypertensive patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, these results should be interpreted with caution owing to potential bias and residual confounders in this observational study.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "39 even so, more rcts to assess the therapeutic effects of chloroquine on covid-19 need to be conducted.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results of the present study revealed the novel finding that sars-cov-2 can be shed in the stool of some convalescent-phase patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results enhance the current knowledge on this emerging infectious disease and offer implications for clinical diagnostics and infection control.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we expect a similar effect against the sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "transmission in healthcare settings can be successfully prevented when appropriate measures are consistently performed [19, 20] .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is suggested that il-6 may be used as a marker for disease monitoring in severe covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "collectively, the dynamic change of il-6 level can be used as a marker for disease monitoring in patients with severe covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest against gamma, and possibly all ionizing radiation, as a method of disposable n95 sterilization.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "even more importantly, they argue against using the qualitative fit test alone to assess mask integrity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study suggests that gender difference is associated with an increase in the likelihood of mers infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "also, our study suggests diabetic patient are more likely to have a confirmed mers infection compared to nondiabetic patients which have been also reported previously in the literature (zumla et al., 2015).\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings suggest the benefit of screening suspected infection and may suggest future preventive therapy.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "taken together, our results suggest 15 that the higher evolutionary rate observed for these two genes could represent a major barrier in the 16 development of antiviral therapeutics 2019-ncov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "comparative studies to determine the impact in vitro of the mutation and loops in rbd of sars-cov and sars-cov-2 are required in order to predict possible zoonotic event in the future.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this study shows that factors determining the diffusion of epidemics similar to covid-19 are due to manifold elements, in addition to human-to-human transmission, given by: general factors that are the same for all locations and associated with innate biological characteristics of the viruses, incubation time, effects on infected and susceptible people, etc.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results indicated that e2 is negatively associated with c3 in follicular phase, and il2r, il6,\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " our observation shows that patients with hypertension who had previously taken acei/arb drugs for antihypertensive treatment have an increased tendency to develop severe pneumonia after infection with sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our survey shows that the population with hypertension does not seem to be more susceptible to covid-19 comparing with the non-hypertension population.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "fourth, we did not analyze the comorbidities such as shock and ards, because our focus is to analyze the risk associated with hypertension to provide evidence for the issue of covid-19 prevention and treatment guidelines.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "interestingly, some of the most potent sars-cov-specific neutralizing antibodies (e.g., m396, cr3014) that target the ace2 binding site of sars-cov failed to bind 2019-ncov spike protein, indicating that the difference in the rbd of sars-cov and 2019-ncov has a critical impact for the cross-reactivity of neutralizing antibodies, and that it is still necessary to develop novel monoclonal antibodies that could bind specifically to 2019-ncov rbd\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results show that darunavir has the best binding affinity with sars-cov-2 and sars-cov 3clpro among all inhibitors, indicating it has the potential to become an anti-covid-19 clinical drug.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study provides insight into the possible role of structural flexibility during interactions between 3clpro and inhibitors, and sheds light on the structure-based design of anti-covid-19 drugs targeting the sars-cov-2 3clpro.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study predicts around ten fda approved commercial drugs that can be used for repurposing.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "among all, we suggest that the antiretroviral drug saquinavir (drugbank id -db01232) would probably be one of the most effective drugs based on the selected criterions.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study can help clinical scientists in being more selective in identifying and testing the therapeutic agents for covid-19 treatment.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "19 our results suggest that 2019ncov is more likely to infect older adult males with chronic comorbidities as a result of the weaker immune func tions of these patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "lz is responsible for summarising all epidemiological and clinical data.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "by providing new information on molecules inhibiting sars-cov-2 replication in vitro, this study could contribute to the short-term repurposing of drugs against covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results specify that tryptanthrin possesses antiviral potential against hcov-nl63 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "on 31 december, 2019, a cluster of 27 pneumonia cases of unknown etiology was reported by chinese health authorities in wuhan city (chinese health authorities in wuhan city\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions in cesarean section for pregnant women with covid-19 infection, csea\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " no evidence supports the use of ether and chloroform inhalation for treating covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "thus we must be vigilant in considering covid-19 even in the atypical patients, as confirmation of more patients at time of presentation will prove critically in stemming the growth of this pandemic.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that the sars-cov main proteases' binding cavity is highly flexible and changes both in volume and shape significantly alter the ligand binding.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this finding indicates a serious obstacle for a classical virtual screening approach and drug design in general.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "such a conclusion may also imply that a sufficiently potent inhibitor of sars-cov and/or sars-cov-2 mpros needs to be able to open its way to the active site before it can successfully bind to its cavity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results support the regulatory role of the c44-p52 loop and again alert against unwarranted use of simplified approaches for drug repositioning or docking.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, our results indicate also residues that are energetically unfavourable to mutate (e.g., p39, r40, p52, g143, g146, or l167), which could provide an anchor for successful drug design that can outlast coronavirus' mpros variability in future.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "alternatively, we would suggest targeting the region between ii and iii domains, which contributes to the dimer formation.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "31.20038935 doi: medrxiv preprint the mechanisms by which arbs/aceis regulate the inflammatory status of covid-19 patients with hypertension.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "indeed, sars-cov-2 can use ace2 but not other tested proteins as a cellular entry receptor in virus infectivity studies using hela cell expressing human ace2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " angiotensin ii receptor blockers and angiotensin-converting enzyme inhibitors usage is associated with improved inflammatory status and clinical outcomes in covid-19 patients with hypertension\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " a case of coronavirus disease 2019 treated with ciclesonide\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " overall our results emphasize that the pk/pd properties of lopinavir/ritonavir, ifn-β-1a 194 and hydroxychloroquine make them unlikely to have a dramatic impact on viral load kinetics 195 in the nasopharynx if they are administered after symptom onset.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, they may be relevant in pre-or post-exposure prophylaxis 202 administration to reduce viral replication and hence the risk of disease progression.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, how to closely observe the condition after morbidity and find severe cases as soon as possible is the key to reduce the mortality of critically ill patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "according to our findings, it seems that the time and speed of production of specific anti-2019-ncov igm antibodies correlate with disease severity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it can be inferred that after the future epidemic situation has been controlled to a certain extent, as a convenient method, antibody detection is still necessary to make differential diagnosis of other respiratory pathogens infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it must be emphasized that independent results of specific antibodies testing should not be used as a diagnostic criteria, especially when the epidemiological history is unclear, and must be combined with the patient's morbidity time and clinical signs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it must be emphasized that independent results of specific antibodies testing should not be used as a diagnostic basis, especially when the epidemiological history is unclear, and must be combined with the patient's morbidity time and clinical signs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results of this study help to provide evidence for rapid screening of suspected cases through the serological testing to curb the rapid progress of the epidemic globally.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "given the large existing manufacturing base and abundance of raw materials for hcq\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " meeting the potential emergency global drug supply challenge of hydroxychloroquine for covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this finding supports a community testing approach supported by clinicians to review the proportion of more unwell patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "11 they highlighted that both sars-cov and mers-cov encode multiple proteins that antagonize ifn responses and that an early antagonism of the ifn response might delay or evade the innate immune response.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "11,12 they concluded that delayed ifn signaling could further orchestrate inflammatory monocyte/macrophage responses and sensitize t cells to apoptosis resulting in a further dysregulated inflammatory response.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings appear to be relatively specific for covid-19 as we have not seen a similar pattern in patients with other viral illnesses, such as h1n1 influenza, hiv, or hantaanvirus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, in patients with severe covid-19 infection, monocyte activation and the associated inflammatory response is associated with characteristic changes that can be rapidly identified by a simple blood-based flow cytometry-based assay, and serially monitored.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "while we acknowledge the limitations of our study, given the small sample size, we feel nevertheless that our findings could be of great help in guiding prognostication and treatment of patients with covid-19 and merit further evaluation and confirmation in future studies.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that lopinavir/ ritonavir may improve the course of covid-19 pneumonia in patients receiving hemodialysis, although the lack of a control patient makes this conclusion somewhat subjective.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results indicate that n95 respirators can be decontaminated and re-used in times of shortage for up to 49 three times for uv and hpv, and up to two times for dry heat.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "black dashed line shows maximum likelihood estimate 65 titer at the limit of detection (lod\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " excitement around hydroxychloroquine for treating covid-19 causes challenges for rheumatology\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " this study conclusively demonstrates that genome-wide codon usage bias in sars-cov-2 coding sequences are similar to what was found in most studied rna viruses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the findings of the present study may help in understanding the underlying factors involved in the evolution of sars-cov-2 viruses and the interactions with their host.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "interpretation: this is the first systematic review investigating the risk factors for severe corona virus disease 2019 (covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusion: our findings suggest that level of ldh, crp, alt and neu\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our pangenomic analysis suggests that the protein e of all sars viruses preserves its critical motifs used for pathogenesis.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "hence, we predict that the readily available and approved inhibitors (amantadine, hexamethylene amiloride and sb203580), that proved efficient for alleviating ards in sars-cov-1-infected animal models should also be effective against sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the high level of conservation of the ic and pbm within clade 2, including sars-cov-1 and sars-cov-2, strongly suggests that the available inhibitors for the e protein of sars-cov-1 should also be active on sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "hence, blocking the sars protein e inhibits development of ards\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " new therapeutic opportunities for covid-19 patients with tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is also exciting to uncover that flavin adenine dinucleotide (fad\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "acetazolamide, nifedipine and phosphodiesterase inhibitors may present an opportunity for countermeasure development.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the utilization of medications found to be effective in hape, for the treatment of covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "thirdly, information about the physical proximity to the index patient were unavailable, therefore we could not quantify the exact risk of in-flight transmission, especially whether degree of illness in passengers was consistent with the physical proximity to the index patient(s).\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " tocilizumab treatment in severe covid-19 patients attenuates the inflammatory storm incited by monocyte centric immune interactions revealed by single-cell analysis\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this review does show however that the existing body of evidence is weighted heavily towards studies of ribavirin which has shown no particular efficacy in treating coronavirus and may in fact cause harmful adverse effects.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "future investigations into potential antiviral therapies for coronavirus may be best served by pointing their attention to other drug candidates.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "there are several limitations to the review methods employed here, single screening and abstraction for example, however they were selected to thoughtfully tailor our methods according to our knowledge user needs and the urgent nature of the request to provide timely results.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results suggest that at the convalescent phase 100% of patients had igg/ igm responses to sars-cov-2, especially to protein n, s1 but not s2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that as long as no disrupting interference occur with both salt bridges at hot spots 31 and 353 coronaviruses are able to bind with hace2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "modeling results suggest that interference with the hot spot 353 could be and effective strategy for inhibiting the recognition of the rbd of the sars-cov-2 spike protein by its human host receptor ace2 and hence prevent infections.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "although additional simulations and experiments are required, all evidence suggests that the mutation of d496 in the bat variants of the coronaviruses permit infection of human cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "giving the large contribution of sars2 k417 to the free energy of binding of the rbd to hace2 we propose that blocking its interaction with the receptor d30 could be a promising strategy for future drug discovery efforts.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results obtained from independent analysis strongly highlight the importance of 439 to 508 section.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these calculations show that the sars2, sars and rs4231 viruses are predicted to favorably bind to the human hace2 receptor, while the rm1 and sars2-mut variants present unfavorable free energies of binding.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the fact that the bat's coronavirus rs4231, in addition to sars and sars2, presents favorable interaction with hace2 is in accordance with the previous observation that it is able to infect human cells expressing this protein (hu et al., 2017) .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this result supports the prediction from fubar analyses indicating that the site g496d is under purifying selection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "combined, our results strongly suggest that the mutation of the d496 residue present in the coronaviruses from bats is critical for their rbds to recognize the human hace2 receptor.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this could indicate that interactions additional to those previously identified with the hace2 hotspots could be critical for the stabilization of the rdb-human receptor complexes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "as a result, the binding of the rbd to hace2 is considerably inhibited and unlikely to occur.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "modeling results indicate that interfering with the salt bridges at hot spot 353 could be an effective strategy for inhibiting binding, and hence for the prevention of coronavirus infections.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we also propose that a glycine residue at the receptor binding domain of the spike glycoprotein can have a critical role in permitting bat variants of the coronaviruses to infect human cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " sars-cov-2, an evolutionary perspective of interaction with human ace2 reveals undiscovered amino acids necessary for complex stability\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study suggests that drugs such as sqv and lpv have shown slightly higher, but comparative binding energies against the sars-cov-2, than hiv-1 protease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results evidence that these compounds could be suitable for further medicinal chemistry optimization to produce the second generation of inhibitors more specific and potent against sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "nevertheless, more pre-clinical and clinical data are required to support the development of new therapies against sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "altogether, the results presented in this work contribute to gain a deep understanding of the molecular pharmacology of sars-cov-2 treatment and validate the use of protease inhibitors against sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we showed that the parp1 inhibitor cvl218 discovered by our in silico drug repurposing framework may have the therapeutic potential for the treatment of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "although we mainly conducted in vitro assays to experimentally validate the anti-sars-cov-2 effects of olaparib and cvl218 due to limited time, it is natural to speculate that other parp1 inhibitors may also have antiviral activities against sars-cov-2 infection, based on our computational prediction and experimental validation results.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "based on the data present in this study and the previously known evidences reported in the literature, we propose several potential mechanisms to help understand the involvement of parp1 inhibitors in the treatment of covid-19 ( figure 6 ).\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "all these studies suggest that parp1 inhibitors are of high relevance to the treatment of the novel pneumonia caused by sars-cov-2 infection, possibly via their roles in modulating inflammatory response.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this finding indicates that cvl218 may also possess the il-6 specific anti-inflammatory effect that is applicable to those severe patients infected by sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "all these evidences indicate the possibility of repurposing parp1 inhibitors as a safe therapeutic agent to treat the current acute lung disease caused by sars-cov-2 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in addition, our pharmacokinetic and toxicokinetic data in rats and monkeys shown in our study indicate that cvl218 may have a relatively acceptable safety profile to be repositioned for the antiviral purpose.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "4 on the other hand, the substrate-binding site of 3cl pro is almost the same between the sars-cov-2 and sars\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we were conclude that covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we suggest that a multivalent construct composed of the sars-cov-2 minigenes (presented in tables 1, s2, and s3) can be used in a dna on mrna vaccine for expression in antigen-presenting cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "acei/arb use does not affect the morbidity and mortality of covid-19 combined with cvd\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, the present study reveals that the fatality rate increases with not only the number of mutations but also depending on its allelic rarity as well as functional alteration of protein.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "future studies may uncover more genetic information at the molecular level as well as structural levels of the proteins, because without this knowledge it'll be difficult to identify drug target and prepare vaccine.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we hope our work will help in that direction.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, these strategies, as proposed here, remain to be clinically tested for effectiveness.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "cluster analysis found more proximities of fbg (at the time of admission) with ldh\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings indicate that the patient's positive nucleic acid test result after hospital discharge was not likely due to relapse; instead, it was more likely due to incomplete clearance of the virus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the nucleic acid test results on the patient's throat swabs were alternately negative and positive, which may be related to factors such as the sensitivity of nucleic acid testing or insufficient virus collection in throat swabs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, an anal test and virus antibody test should be considered in future because such tests may help to rule out positive cases among discharged patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in particular, if igm is negative and igg is positive in a discharged patient with covid-19, then protective antibodies have been produced and centralized isolation is not needed; this may greatly reduce medical costs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this is the first study showing an association between kidney involvement and poor outcome in patients with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we found that patients with elevated baseline serum creatinine were more likely to be admitted to the intensive care unit and to undergo mechanical ventilation, suggesting that kidney disease on admission represented a higher risk of deterioration.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "12 we found that patients with elevated serum creatinine were more likely to develop aki during hospitalization, which is consistent with study in sars.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "5 it is therefore important to increase the awareness of aki in those who entered the hospital with an elevated serum creatinine.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in our cohort, the detection rate of aki in patients with covid-19 was 5.1%, which is in keeping with recent reports of small sample size 1,4,7,13 and much higher than the 0.5% of a large observational study.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "14 this may be explained by an extremely high proportion of severely sick patients in a previous case series and only 15.7% in the large observational study.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in our cohort study, 42.7% of patients were severely ill, and this may explain the higher detection rate of aki in clinic practice in wuhan.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "early detection and effective intervention of kidney involvement may help to reduce deaths of patients with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "additionally, we propose structural and function implications of two previously identified rdrp this study highlights the importance of considering the balance between incorporation and excision properties of nas between the rdrp and exon.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "based on these results, we propose here that jak inhibitors are a valid therapeutic approach for attenuating the cytokine storm in covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, our findings show that the development of covid-19 can cause hepatic impairment in these 14 patients, which is consistent with the observations that a large number of covid-19 patients showed liver function abnormalities (table s13) (6) .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "besides, our data show that the metabolic pathway of glycerophospholipids has been significantly changed, and glycerophospholipids are closely related with cardiovascular diseases.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, this finding suggests that the fatality caused by covid-19 might be related with cardiac impairment.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "one might speculate a cause-and-effect relationship wherein more frequent exposure of the other groups to the noted materials in some way protected them from reaching the most severely impacted category, but our cross-sectional results are, by nature, correlational.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this study limitation does not detract, however, from the importance of widely implementing prevention and monitoring strategies; mildly to moderately impacted personnel expressed interest in having access to psychological guidance materials, which provides evidence of the importance of prevention strategies.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, the results demonstrate that a strikingly large portion of health care providers in virus-plagued wuhan are suffering from mental health disturbances.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "they would benefit from greater availability of personalized mental health care from psychotherapists and psychiatrists, wherein different mental health groups could focus on providing specialized mental healthcare services.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "among the steps needed to better prepare for future infectious disease outbreaks would be a greater investment in the mental health tools in society's medical arsenal to protect and care for future medical and nursing staff who find themselves unexpectedly on the dangerous front lines of disease response.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that sars-cov-2 might be excreted at low levels despite clinical recovery.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "thus, both serial viral load monitoring and antibody response should be considered when making decisions about infection control measures, because viral load seemed to be related inversely to serum antibody response in this study.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings showing correlation between antibody level detected by eia and virus neutralisation titre are especially important for design of vaccine studies, and use of convalescent plasma or therapeutic monoclonal antibodies, which could improve clinical outcome or paradoxically cause immuno pathological damage to the recipient.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "further virological and immunological studies are needed to understand sars-cov-2 infection; infection control measures should be reviewed with the rapidly evolving epidemiology of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we propose that the immunomodulatory effect of hydroxychloroquine also may be useful in controlling the cytokine storm that occurs late-phase in critically ill severe acute respiratory syndrome coronavirus 2 infected patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions: hydroxychloroquine was found to be more potent than chloroquine to inhibit severe acute respiratory syndrome coronavirus 2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " in vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (sars-cov-2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, more in vitro and in vivo researches should do to finally confirm the safety, efficacy and potentiality of the predicted vaccines candidates.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "reliance on d-dimer as a screening tool should be discouraged in this patient population and may lead to over utilization of computed tomography angiography (cta\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "considering the significance of this ongoing global public health emergency, although our conclusions are limited by the small sample size, we believe that the findings are important to understand the clinical characteristics and sars-cov-2 reactivation potential in covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the association with rsv was not supported following a correction for multiple comparisons, although previous studies also report a high proportion of scov coinfections with rsv further work is needed to establish the role of viral coinfections in covid-19 severity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the structure presents here serves as an important framework to dissect the mechanism of 2019-ncov infection and may facilitate development of potential therapeutics.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "all these data indicate that furin might play a pivotal role in the pathogenicity of sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the evolution trends of increasing fcs in sars-cov-2 we found in this study are more prone to influenza-like clinical manifestations such as human hku1 and oc43 42 .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "sars-cov-2 may adopt a similar mechanism by depending on furin for invasion as hju1 and oc43.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "such potential evolution direction may promote the appearance of mild subtype of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "china’s plan of tocilizumab treatment has shown its remarkable effectiveness and safety in clinical practice over the past 2 months, hoping it will benefit other countries fighting the pandemic and reduce the mortality of severe covid-19 as well.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, we suggest that tocilizumab is an effective treatment in severe patients of coronavirus was identified in december 2019\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " why tocilizumab could be an effective treatment for severe covid-19?\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we suggest that apart from carefully selecting donor-recipient pairs, transplantation is not advisable during this pandemic, especially for older recipients with comorbidities, in particular diabetes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in our series, the observation that 4 of 7 patients had aki (57%) may be an early signal that transplant patients are at higher risk of aki with covid-19 infection, compared with 29% aki in critically ill patients of general population in wuhan, china\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study underlines the need to register as much details as possible on clinical trials registries during outbreaks in order to inform the development of future trials.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results might inform the adaptation of existing clinical trials and the development of additional trials.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest a number of potential diagnosis biomarkers and angiotensin receptor blocker (arb\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "16.20037135 doi: medrxiv preprint for ethical reasons and because our first results are so significant and evident we decide to share our findings with the medical community, given the urgent need for an effective drug against sars-cov-2 in the current pandemic context.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we show here that hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of sars-cov-2 in covid-19 patients in only three to six days, in most patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results are of great importance because a recent paper has shown that the mean duration of viral shedding in patients suffering from covid-\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, its administration should be done under medical control to avo id potential side effects and to prevent an uncontrolled use leading to supply shortages.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof j o u r n a l p r e -p r o o f journal pre-proof\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "10 summarizes the potential mechanisms of sars-cov2 associated complement activation, and its possible interaction with coagulation pathways.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "given these data, use of agents that block lp activation at mbl recognition domains, shows a significant degree of c4d and sars-cov2 co-localization, as revealed by intense yellow staining.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "e-h: a similar pattern was observed using an anti-c5b-9 reagent whose image appears green, with a significant degree of c5b-9 and sars-cov2 co-localization, as revealed by intense yellow staining.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results pave the way for using s309 and 37 s309-containing antibody cocktails for prophylaxis in individuals at high risk of 38 exposure or as a post-exposure therapy to limit or treat severe disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that they may recognize 105 post-fusion sars-cov-2 s, which was recently proposed to be abundant on the 106 surface of authentic sars-cov-2 viruses 31 (fig.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this result indicates that one or more igg-specific bivalent 180 mechanisms, such as s trimer cross-linking, steric hindrance or aggregation of 181 virions 37 , may contribute to the ability to fully neutralize pseudovirions.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings suggest that adcp by 198 monocytes was dependent on both fcgriiia and fcgriia engagement.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "collectively, 199 these results demonstrate that in addition to potent in vitro neutralization, s309 may 200 leverage additional protective mechanisms in vivo, as previously shown for other 201 antiviral antibodies 41,42 .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is therefore a promising lead compound 38 for the development of new antivirals to target covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we hope our data will help guide evidenced-based decisions and future experiments that will protect health care providers fighting sars-cov-2 and other pathogens.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we speculate that the almost ubiquitous expression of furin-like proteases could participate in expanding sars-cov-2 cell and tissue tropism, relative to sars-cov, as well as increasing its transmissibility and/or altering its pathogenicity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "collectively, these data underscore that s glycoprotein trimers found in highly pathogenic human coronaviruses appear to exist in partially opened states, while they remain largely closed in human coronaviruses associated with common colds.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we note that most sars-cov neutralizing abs isolated to date target the s b domain and that several of them recognize the rbm and prevent receptor engagement (hwang et al., 2006; rockx et al., 2008; rockx et al., 2010; traggiai et al., 2004; walls et al., 2019) .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "as the sars-cov-2 and sars-cov s b domains share 75% amino acid sequence identity, future work will be necessary to evaluate whether any of these abs neutralize the newly emerged coronavirus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings also indicate that it might be difficult to distinguish exposure to sars-cov-2 from other sarsr-covs in serological studies using s ectodomain trimers and that specific assays will need to be designed.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results provide a structural framework to identify conserved and accessible epitopes across s glycoproteins that will support italic font indicates the absence of a glycosylation sequon and deletions are indicated with periods.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "finally, elicitation of diverse, polyclonal ab responses might prove key in light of the diversity of viruses circulating in animal reservoirs and in preventing the possible emergence of viral neutralization escape mutants.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results suggest that patients may experience severe hypoxia, resulting in aggravated multiple organs damage.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it should not be overlooked that sars-cov-2 might also directly attack multiple organs, especially the kidneys.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the study results suggest that early intervention after the occurrence of aki is very important, and that continuous renal replacement should be considered to help alleviate the progress of aki.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "indeed, our analysis suggests that inhaled ifn-α2b accelerated viral clearance from the respiratory tract and hastened resolution of systemic inflammatory processes when compared to arb treatment alone.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "while we recognize that these data are at best suggestive, given the urgency, the findings indicate that a follow-up randomized placebo controlled clinical trial (rct the copyright holder for this preprint (which was not peer-reviewed) is the .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results indicate that an ifn-α rct is now warranted.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings suggest that ifn-α2b should be further investigated as a therapy in covid-19 cases.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "even though we verified very weak binding of sars-cov-2 spike protein to ace in our simulations, we urge that the hypothesis that ace, which is highly expressed in lung tissue, is an alternative receptor for sars-cov-2 should be thoroughly tested experimentally in humans and potential zoonotic reservoirs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our analyses suggest that ace could be a secondary receptor for sars-cov-1 in the absence of ace2, and it may have played a subtle but important role for the sars outbreak.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "as we learn more about how neural circuits drive behavior … we can start implementing that knowledge, in terms of treating human diseases.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "i am hopeful that brain research through advancing innovative neurotechnologies, with other efforts in nih\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, esr can be used as a powerful indicator to predict disease severity in sars-cov-2 infected patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in conclusion, this study provides a correlation between clinical parameters and disease severity of covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study of mild and severe patients demonstrates that these clinical parameters, including esr, d-d, age, alb and il6 are closely related with the disease progression of covid-19 patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "among these parameters, esr has the best performance and can be used as an effective indicator to predict the severity of disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study may help to identify severe covid-19 patients in early stage, in order to provide supportive treatment and reduce the mortality.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this is of clear significance given the interest in the s\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " characterisation of the transcriptome and proteome of sars-cov-2 using direct rna sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results show that, despite all being classified as the same virus species, most lineage b β-covs do not use currently known coronavirus receptors ( figure 1e, 3a, b) .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these finding suggests 2019-ncov is capable of using human ace2 as efficiently as sars-cov, which may help explain the human-to-human transmissibility of this virus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these data show that the chimeric spikes generally reproduce the entry phenotypes of full-length spikes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "rapid mutations accumulating in orf3a should be closely monitored throughout the covid-19 pandemic.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the high mortality rate of this population suggests aggressive management is needed for kidney transplant patients with sars-cov2 infection, in particular early hospitalization should be considered in case of pneumonia; furthermore more effective treatment protocols need to be identified.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our study has limitations: the sample size is small and the median follow-up short; findings are, therefore, preliminary and will need to be confirmed in bigger cohorts with longer followup.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "some strengths may be acknowledged as well and in particular the monocentric approach and the homogeneity of the clinical treatment employed.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "currently, a randomized controlled trial evaluating the efficiency of high-dose ivig therapy in severe covid-19 has been initiated (nct 04261426), which will provide more evidence for ivig use in treating such patients.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the covid-19 pandemic?\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is necessary to strengthen the monitoring of covid-19 and to develop drugs and vaccines against the covid-19 infection as soon as possible.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "to conclude, controlling this highly transmissible disease requires international co-ordination.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our analysis indicates that the outbreak occurred a few months earlier than it was officially reported, and there might be recessive infection and underdetection in the population.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " remdesivir inhibits renal fibrosis in obstructed kidneys\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our data show significant variability in genetic determinants of ace2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results therefore discourage confinement by age as the only exit strategy.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we urge brazilian authorities to take action to prevent virus dissemination in the critical coming weeks.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " the present study provides evidence that host cell entry of sars-cov-2 depends on the sars-cov receptor ace2 and can be blocked by a clinically proven inhibitor of the cellular serine protease tmprss2, which is employed by sars-cov-2 for s protein priming.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "moreover, it suggests that antibody responses raised against sars-cov could at least partially protect against sars-cov-2 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results have important implications for our understanding of sars-cov-2 transmissibility and pathogenesis and reveal a target for therapeutic intervention.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the finding that sars-2-s exploits ace2 for entry, which was also reported by zhou and colleagues (zhou et al., 2020) while the present manuscript was in revision, suggests that the virus might target a similar spectrum of cells as sars-cov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the present study indicates that sars-cov-2 spread also depends on tmprss2 activity, although we note that sars-cov-2 infection of calu-3 cells was inhibited but not abrogated by camostat mesylate, likely reflecting residual s protein priming by catb/l.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "one can speculate that furin-mediated precleavage at the s1/s2 site in infected cells might promote subsequent tmprss2-dependent entry into target cells, as reported for mers-cov (kleine-weber et al., 2018; park et al., 2016) .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "although confirmation with infectious virus is pending, our results indicate that neutralizing antibody responses raised against sars-s could offer some protection against sars-cov-2 infection, which may have implications for outbreak control.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in sum, this study provided key insights into the first step of sars-cov-2 infection, viral entry into cells, and defined potential targets for antiviral intervention.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in the simulations, ritonavir can bind to cep_c30 most suitably, and induce significant conformation changes of cep_c30; lopinavir can also bind to cep_c30 suitably, and induce significant conformation changes of cep_c30; darunavir can bind to plvp suitably with slight conformation changes of plvp.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "it is suggested that the therapeutic effect of ritonavir and lopinavir on covid-19 may be mainly due to their inhibitory effect on cep_c30, while ritonavir may have stronger efficacy; the inhibitory effect of darunavir on sars-cov-2 and its potential therapeutic effect may be mainly due to its inhibitory effect on plvp all rights reserved.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " molecular modeling evaluation of the binding effect of ritonavir, lopinavir and darunavir to severe acute respiratory syndrome coronavirus 2 proteases\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these evidences suggest that sars-cov-2 infection may be associated with cellular immune deficiency and lead to acute myocardial injury and kidney injury.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results also support the described organ injury above.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " findings from this meta-analysis supported the hypothesis that liver injury is associated with severe outcomes in patients with covid-19 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "to our knowledge, this study is the first systematic review and meta-analysis to assess the association between serum levels of ast, alt, total bilirubin and albumin with severity of covid-19 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions: the incidence of liver injury seems to be higher in patients with severe covid-19 this finding could help physicians to identify patients with poor prognosis at an early stage.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "journal pre-proof j o u r n a l p r e -p r o o f\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusion: chest computed tomography offers fast and convenient evaluation of patients with suspected 2019-novel coronavirus pneumonia.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these data indicate that auranofin could be a useful drug to limit sars-cov-2 infection and associated lung injury due to its anti-viral, antiinflammatory and anti-ros properties.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggest that both apobecs and adars are involved in coronavirus genome editing, a process that may shape the fate of both virus and patient.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in the future, it may be possible to design a technique that avoids the need to flip masks over and irradiate\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "most of the studies found in this article are scheduled to end in 2020, and we hope these repositioning trials may help to find solutions for covid-19 treatment by this year.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in this study, we hope to discover evidence either supporting or opposing the systemic therapeutic administration of glucocorticoids in severe coronavirus disease 2019 (covid-19\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "interpretation in this study, we found that lmwh\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in the case of elevated d-dimer levels on admission or sudden clinical worsening, ct pulmonary angiography should be considered since pulmonary embolism is a life-threatening but potentially treatable condition.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions: we conclude that patients at old age, males, and/or having diseases associated with high expression of ace2\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we hypothesize that high concentrations of inhaled no\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results together with the known immune properties of ivig, suggest a potential positive contribution of currently available ivig products to covid-19 disease management.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these preparations may be useful for immediate treatment of covid-19 disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we find that the false positive rate is high for all tested tools when testing for predicted hla-binding peptides from sars-cov-2 virus.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this creates a challenge for vaccine development efforts, especially for the design of epitope vaccines, where only a limited number of epitopes may be included.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we hope that this contribution will aid the development of a vaccine against sars-cov-2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings suggest that the performance of current state-of-the-art epitope prediction tools are impacted by the varying quality of publicly available data.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we concluded that if ace2 is the only route for the infection in humans, variants interacting physically with rbd are not likely to disrupt the formation of the complex and would have a marginal effect on the affinity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, it is unlikely that any form of resistance to the virus, related to .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this suggests that the molecular elements required for the binding with the receptor might also be involved in the interaction with other orthologous forms of ace2 and that these elements are not optimized specifically for the human form.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "therefore, it is unlikely that the interface of rbd from sars-cov-2 is a result of human intervention aiming to increase the affinity toward ace2.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "https://doi.org/10.1101/2020.03.04.976027 doi: biorxiv preprint for the mutation of the new virus which would allow it to cross the species barrier more easily and to efficiently optimize the interaction in the host.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "long-term outcomes and potential mother-to-child vertical transmission needs further study.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "some scholars may not support the corticosteroids treatment for novel coronavirus pneumonia (ncp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " potential benefits of precise corticosteroids therapy for severe 2019-ncov pneumonia\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "such lr interactions revealed here the main differences between the proteases of cov-1 and cov-2, as well as the most important amino acids for the interaction with inhibitors, which may produce therapeutic candidates against covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "early supportive therapy should been provided to control disease progression and reduce the mortality of covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "early support should be provided, especially for old men with chronic disease, which is vital to control disease progression and reduce mortality of covid-19 during epidemic ongoing outbreak.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results, together with replication inhibition by remdesivir of a wide range of coronaviruses in vitro and in vivo (7), may further indicate utility of remdesivir against the novel coronavirus 2019-ncov emerging from wuhan, china (26).\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the data presented here support testing of the efficacy of remdesivir treatment in the context of a mers\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "all these findings have significant potential for cross-talk with nets.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "biorxiv preprint therefore, we suggest that, these positions can be targeted for drug development against covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "thus, we suggest these sites as critical sites for s1 protein activity.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we suggest these positions as a potential target for the inhibition of the initial binding of sars-cov-2 s1 protein to the host cell.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions the results of this real world study might provide clinical practitioners a high efficiency and fast antivirus regimen for ncp\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "meanwhile, our crystal structures may be used by others for virtual screening and de-novo design of inhibitors.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "while we demonstrate that the pac-man system is able to exhibit strong repression of viral sequences in an in vitro setting, it must be coupled with an effective in vivo delivery system for therapeutic use.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "5a ) could be delivered simultaneously 9 , further reducing the chances of viral escape.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "as a further advantage, we demonstrate a potential pan-coronavirus strategy to target not only viruses that circulate in humans, but also those that currently are found in animal reservoirs that might transfer to humans to cause disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "if the crrnas targeting these viruses can be tested and validated before they ever infect humans, we can greatly accelerate the development of countermeasures for future emergent threats.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in summary, our pac-man strategy represents a potentially powerful new approach for inhibiting viral function and replication, and we envision it could be useful for a diverse array of circulating and emergent viral threats.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this exciting finding suggested that return of normokalemia might be a reliable biomarker for monitoring ace2 function.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the results indicated that virus might directly bind to ace2 positive cholangiocytes but not necessarily hepatocytes.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this finding suggested the liver abnormalities of sars an very recent epidemiologic study revealed that 43 out of 99 initial patients infected with 2019-ncov had various degrees of liver function abnormality, with alanine aminotransferase (alt) or aspartate aminotransferase (ast\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our data suggest that ace2 is specifically expressed by colonocytes and positively associated with viral entry and egress, consistent with observations that the gastrointestinal tract is a potential route for 2019-ncov infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings may facilitate concurrent and future investigations of the nature and function of the immune system at systemic and local levels in patients with 2019-ncov pneumonia.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "by intersecting these age-associated changes with prior experimental data on host interactions between sars-cov-2 or its relative sars-cov, we identify several age-associated factors that may contribute to the heightened severity of covid-19 in older populations.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these analyses illuminate potential avenues for further studies on the relationship between the aging lung and covid-19 pathogenesis, which may inform strategies to more effectively treat this disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we emphasize that our findings are not intended to direct clinical practice, but rather to generate hypotheses and to further guide research efforts that can improve our understanding of this disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "of note, biological sex was not significantly associated with expression of ace2, tmprss2, or ctsl (supplementary figure 2a-c) , though it has been observed that males are more likely to be affected by covid-19 than females16-18.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "this map would be helpful for personalized medicine in the future.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "moreover, ace2, the target of 2019-ncov, was only found in parts of lung cells, which makes drugs like chloroquine that prevent virus binding to ace2 more specific than other targeted drugs such as camostat mesylate.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "perhaps it benefits the virus to block an inflammatory response by inhibiting the dehydrogenase, but a fairly complex web involves several possible targets.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "amantadine would be predicted by physical and chemical properties to accumulate in the lysosomes and raise a the ph, likely enough to interfere with cathepsin l function.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the gene expression pattern reported in this paper suggests that a more general lysosomal program is down-regulated, likely through a common set of transcription factors.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "also, potential drugs listed in table 1, such as remdesivir, atazanavir, saquinavir, and formoterol, and tocilizumab can be introduced as treatments for covid-19 if they prove to be effective in animal and clinical studies.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our findings also highlight the importance of planning for mass critical care as the need for icu care and ventilatory support to treat patients with covid-19 grows rapidly in the united states.22,23\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "here we highlight that sars-cov2 seems to be also interfering with ace2 expression, which could be related to a higher level of lung injury as it was demonstrated for sars-cov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "when inspecting the quantitative data for other proteins in the renin-angiotensin system, two other proteins were found to be downregulated 24 h post-infection cathepsin a (ctsa) and angiotensinogen (agt\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "preliminary results with ionized hydrogen peroxide sterilization (ihp; tomi steramist™) 10 suggests that panfab face shields can be successfully sterilized without suffering damage through at least five cycles.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " the inhaled corticosteroid ciclesonide blocks coronavirus rna replication by targeting viral nsp15\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "rt-lamp has the potential to transform covid-19 detection, bringing rapid and accurate testing to the poc.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusively, this study suggests that pangolin species are a natural reservoir of sars-cov-2-like covs.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "third, this study was limited to the local investigation, and the findings may be inconsistent with nationwide or worldwide studies, which may decrease its credibility.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusions: our study suggested that patients with severe covid-19 may be more likely to have an older age, present with lymphopenia and bilateral lung infiltration, receive multiple treatments and stay longer in hospital.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings indicated that early and high dose of ivig therapy may improve the prognosis of covid-19 patients only in critical type, which provide the clinical basis for the choice of treatment population and method of ivig therapy for the sars-cov-2 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results suggested that the dose of immunoglobulin should be over 15 g/d (>~0.3g/kg.d), providing a reference for the clinical treatment in covid-19 infection.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we found that early and high dose of ivig therapy may improve the prognosis of covid-19 patients with critical type.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these findings provide the clinical basis for the choice of treatment population and method of ivig therapy for the covid-19 infection and help to increase effective of treatment in this spreading disease.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "our results strongly suggest that cep is a wide-spectrum inhibitor of pan-betacoronavirus, and clinical trial of cep for treatment of 2019-ncov\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "the literature did, however, suggest a potential role for low-dose corticosteroids to reduce levels of pro-inflammatory markers, such as il-1, which are elevated as part of the immune response and may have a role in the severe lung damage associated with human coronaviruses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in vitro treatment with glycopyrronium, formoterol and budesonide exerted additive inhibitory effects on viral titers and cytokine production human nasal and tracheal epithelial cells.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " the current literature does not give conclusive evidence for or against the use of nsaids in the treatment of covid-19 patients, though there appears to be some evidence that corticosteroids may be beneficial in the treatment of sars-cov.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "however, it is important to note this is not specific to covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "further study is warranted, both in the clinical setting and laboratory.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "ongoing studies of blockade of the il-6 pathway are rational and will hopefully inform practice as the pandemic progresses.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "secondly, when the search space was expanded to all fda-approved drugs, some immunosuppressant drugs (rapamycin and everolimus) and a drug (tiotropium bromide) for asthma and chronic obstructive pulmonary disease (copd we hope our prediction results may support experimental therapeutic options for china and other countries suffering from the sars-cov-2 pandemic and align with recent clinical trials (35) .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "overall, we suggest that the list of antiviral drugs identified by the mt-dti\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "acei/arb use does not affect the morbidity and mortality of covid-19 combined with cvd\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these results indicated that in covid-19 associated liver dysfunction and cell death, viral infection of trop2 + progenitors in liver may significantly impaired liver regeneration and could lead to pathology.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "-epcam + liver progenitors co-express ace2 and tmprss2 -ace2 and tmprss2 expression is highest in trop2 high progenitors -ace2 and tmprss2 cells express cholangiocyte biased fate markers -ace2 and tmprss2 positive cells are absent in human fetal liver .\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "in pitavastatin-2gtb, perampanel-5nh0, and praziquantel-3v3m, the van der waals interaction (e vdw ) makes a more significant contribution than the electrostatic interaction (e ele ) (\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " nelfinavir was predicted to be a potential inhibitor of 2019-ncov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "we hope that our report will be helpful to stimulate pharmacovigilance and monitoring of adverse drug reactions with the use of cq or hcq\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "these early data will require confirmation as the pandemic establishes around the world.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      " hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting sars-cov-2 infection in vitro\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "more data are needed to gain better understanding of ktx recipients infected with covid-19.\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "conclusion joint detection of serum igm and igg antibodies to 2019-ncov is an effective screening and diagnostic indicators for 2019-ncov\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n",
      "<class 'str'>\n",
      "[]\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for claim in df.claims:\n",
    "    print(type(claim))\n",
    "    print(claim)\n",
    "    print('\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [],
   "source": [
    "claims = [i for i in df.claims if len(i) > 2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(701, 5)"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "claims_df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
